rfhg_99027.1

Basic information about the TSS

---

TSS ID: rfhg_99027.1 Species: human Chr: chr7		Start: 116525701 End: 116525759 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4020659,EH38E2583974)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000405348.6:-170 GeneID: 857 HGNC/MGI_ID: HGNC:1527 UniProt_ID: A0A024R757 Nearer transcript ids and distances: ENST00000456473.5:223

Gene_name: caveolin 1 Gene_symbol: CAV1 Gene_synonyms: Gene_source: HGNC:1527

TATA-Box annotation

---

Distance to TSS:	-632
Nearest PromoterID:	NM_001172897
Entrez ID:	857
Nearest Unigene:	Hs.74034
Nearest Refseq:	NM_001753
Nearest Ensembl:	ENSG00000105974
Gene Name:	caveolin 1
Gene Alias:	BSCL3|CGL3|LCCNS|MSTP085|PPH3|VIP21
Gene Type:	protein-coding
CpG%:	0.068966
GC%:	0.644068
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CAV1 p2@CAV1 p3@CAV1 p4@CAV1 p5@CAV1 p6@CAV1 p7@CAV1 p8@CAV1 p9@CAV1 p10@CAV1
Sample		p1@CAV1	p2@CAV1	p3@CAV1	p4@CAV1	p5@CAV1	p6@CAV1	p7@CAV1	p8@CAV1	p9@CAV1	p10@CAV1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	18.51	2.53	0.97	0.19	0.00	0.19	0.39	0.00	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	14.57	3.03	0.20	0.61	0.00	0.20	0.20	0.00	0.00	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	19.48	2.70	0.58	0.77	0.00	0.19	0.19	0.00	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	19.13	1.66	0.83	0.62	0.00	0.42	0.00	0.00	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	21.60	2.02	0.45	0.67	0.00	0.22	0.22	0.45	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.80	2.13	0.97	0.58	0.00	0.19	0.00	0.00	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	30.94	2.40	1.09	0.44	0.00	0.65	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	24.46	1.70	0.73	0.24	0.24	0.00	0.24	0.00	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	20.73	1.50	0.85	0.85	0.21	0.64	0.00	0.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.75	1.74	1.74	0.00	0.58	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.94	0.81	2.02	1.62	0.00	1.62	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.60	0.41	1.22	0.00	0.00	0.41	0.81	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	54.00	15.47	7.25	1.77	2.42	0.48	0.16	1.61	0.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	43.75	19.40	6.01	1.05	2.41	0.60	0.45	1.20	0.45	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	50.72	18.66	6.37	0.44	1.32	1.32	0.22	0.44	0.44	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	54.07	18.61	6.04	1.51	1.01	0.75	0.00	1.01	0.50	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	44.12	20.53	6.99	1.31	1.53	0.22	0.00	0.66	0.22	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	42.60	21.93	5.48	1.27	3.37	0.42	1.27	2.53	1.27	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	50.65	21.33	3.73	2.67	4.27	0.53	0.00	1.60	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	40.47	17.75	5.12	2.41	1.65	0.30	0.60	2.71	1.05	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	42.63	22.99	4.68	2.54	1.34	0.40	0.80	1.34	0.80	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	37.80	21.41	6.39	1.90	1.38	1.04	0.35	1.38	0.86	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	50.80	24.95	6.98	1.55	1.68	0.13	0.39	0.65	0.26	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	41.50	19.41	4.61	1.94	2.91	0.24	0.24	2.67	0.73	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	38.18	20.64	4.64	1.55	4.13	0.77	0.26	2.06	0.26	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	37.98	19.94	5.38	1.90	1.58	0.63	0.00	0.95	0.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	35.71	21.98	6.59	3.30	1.65	0.55	0.00	2.75	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	45.03	20.04	8.72	1.89	2.59	0.24	0.00	1.18	0.24	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	38.93	15.83	4.85	1.45	1.78	0.32	0.16	1.13	0.81	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	47.41	18.28	5.79	1.63	1.09	0.18	0.36	2.90	0.18	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	35.80	17.79	4.61	3.14	2.51	0.21	0.00	2.93	0.42	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	33.80	18.56	6.64	1.76	0.98	0.20	0.20	1.95	0.39	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	31.23	15.19	5.28	1.48	2.32	0.00	0.42	1.27	1.06	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	35.30	22.76	7.59	0.99	2.14	0.49	0.16	1.65	0.33	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	35.53	22.06	4.86	1.50	1.68	1.31	0.37	2.06	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	35.64	17.25	2.30	1.53	1.53	0.57	0.38	1.34	0.38	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	33.72	17.78	5.72	1.02	1.43	0.00	0.00	0.82	1.02	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	38.28	17.13	4.63	2.01	1.61	1.01	0.20	0.20	0.60	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	36.19	20.80	5.40	1.08	2.70	0.81	1.35	1.62	0.54	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.57	14.16	2.40	2.16	2.64	0.24	0.00	2.40	0.24	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	33.88	13.41	4.71	0.94	2.59	0.71	0.00	0.94	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.16	16.84	6.00	1.90	1.76	1.17	0.15	1.32	0.15	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	30.79	11.81	5.27	2.53	1.69	0.42	0.42	1.48	0.63	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	34.27	14.86	3.85	4.02	1.57	0.52	0.00	2.27	0.35	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	32.93	16.66	5.02	2.81	2.41	2.01	0.60	2.21	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	29.08	17.22	5.12	1.63	1.63	2.09	0.70	2.79	1.40	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	28.07	13.19	4.08	3.12	0.96	0.96	0.24	1.92	0.00	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	33.08	13.41	5.36	2.38	0.89	0.60	0.00	1.79	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.26	12.69	2.15	2.87	0.96	0.48	0.96	1.91	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.83	10.51	2.63	3.84	1.62	0.40	0.61	1.82	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	28.49	11.07	2.05	2.05	0.61	0.20	0.00	1.02	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	25.13	12.68	3.56	2.00	0.44	0.67	0.22	0.89	0.22	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	28.39	17.39	3.19	4.26	2.13	0.71	0.71	1.06	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.88	11.93	1.33	4.31	0.66	2.32	0.33	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	14.26	11.75	6.71	0.00	0.00	0.84	0.00	0.84	0.84	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	23.42	16.99	4.13	0.46	0.92	0.92	0.46	0.92	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	17.83	8.10	1.94	2.59	0.65	1.62	0.32	0.65	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.95	6.42	1.28	3.21	2.25	3.21	0.96	0.32	0.32	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.14	8.17	3.46	1.26	1.26	0.94	0.31	0.31	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	5.64	2.12	0.71	3.53	1.41	1.41	0.00	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.29	3.93	1.12	3.93	0.00	0.00	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.17	3.18	0.80	0.80	1.59	1.59	0.00	4.78	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	4.76	3.40	1.02	1.02	0.68	2.04	0.68	0.34	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	3.57	1.95	0.32	3.57	0.97	0.97	0.32	0.32	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	3.90	0.71	0.00	4.61	0.71	1.77	0.35	0.71	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	0.00	0.00	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	27.79	1.46	0.00	2.93	0.98	2.44	0.00	0.49	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	29.26	5.45	0.99	4.96	0.50	4.46	0.00	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	23.92	4.22	0.94	5.63	0.47	1.88	0.47	0.94	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	54.65	8.28	0.99	4.31	0.99	6.62	0.00	1.32	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	59.70	7.11	1.24	8.04	1.86	7.73	0.62	1.24	0.00	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	55.65	6.11	2.14	8.87	1.22	7.34	0.31	1.83	0.61	1.53
Adipocyte - breast, donor1	11376-118A8	460.90	192.44	135.74	12.51	12.04	2.06	0.79	3.48	2.53	0.95
Adipocyte - breast, donor2	11327-117E4	477.27	142.62	77.17	6.26	8.98	2.57	0.96	2.25	4.97	2.57
Adipocyte - omental, donor1	11473-119C6	402.04	173.79	116.79	12.47	9.80	3.56	1.78	1.65	2.67	0.25
Adipocyte - omental, donor2	11474-119C7	208.55	79.23	57.56	12.71	6.73	4.48	0.00	1.49	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	334.92	68.66	35.17	4.02	5.69	2.34	0.33	2.34	0.67	1.34
Adipocyte - perirenal, donor1	11476-119C9	151.20	47.85	33.81	8.93	10.21	1.28	1.91	5.10	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	139.64	61.57	24.19	3.30	2.20	0.00	0.00	0.00	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	723.50	316.14	234.39	4.52	5.87	0.90	0.45	1.35	2.26	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	514.72	113.13	53.87	2.95	2.43	0.70	0.52	1.74	1.22	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	425.56	44.98	18.38	1.37	4.11	0.78	0.20	0.20	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	38.09	5.92	1.80	0.00	0.51	0.00	0.00	0.00	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	381.08	57.43	29.83	3.35	4.18	0.84	1.39	1.39	1.39	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	662.46	37.03	9.99	5.88	4.70	0.59	0.00	1.18	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	1917.45	103.36	64.35	6.52	12.71	2.49	2.25	0.88	0.88	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	370.85	12.91	8.39	1.29	3.87	0.00	1.29	0.65	2.26	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	702.74	74.11	24.53	1.60	4.80	0.53	1.60	2.13	3.20	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	1022.17	77.34	35.61	5.56	6.12	1.67	2.23	3.34	1.11	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	972.36	37.43	17.88	5.41	14.56	1.25	0.42	2.91	1.25	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	495.55	31.14	11.55	2.01	4.77	1.26	1.26	0.25	1.26	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	857.38	60.87	19.96	4.25	4.91	0.65	1.96	1.96	0.98	2.62
Adipocyte differentiation, day12, donor4	13030-139E6	1176.48	22.53	12.18	5.48	11.87	1.52	1.52	2.13	1.22	1.52
Alveolar Epithelial Cells, donor1	11510-119G7	179.23	43.32	24.75	8.62	2.65	2.65	1.77	0.22	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	59.52	9.32	3.23	2.15	1.08	1.79	1.08	1.08	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	57.50	8.39	3.59	1.20	0.00	2.40	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	324.01	95.35	52.89	6.30	1.98	0.54	0.54	0.90	0.72	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	162.33	51.88	21.76	5.02	0.00	0.00	1.67	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	220.44	79.71	42.32	5.14	1.03	0.62	1.03	0.82	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	258.95	284.81	120.03	4.69	7.90	1.26	1.26	0.46	0.69	0.34
Anulus Pulposus Cell, donor2	11463-119B5	316.66	181.97	63.43	6.61	6.12	1.96	1.96	1.47	0.49	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	182.86	131.64	102.44	4.49	0.90	0.90	0.45	1.35	1.80	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	175.39	140.66	121.13	5.64	3.91	2.60	2.60	3.04	1.74	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	100.59	79.19	72.77	0.00	0.00	0.00	0.00	10.70	10.70	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	151.25	103.13	80.41	5.98	2.99	0.30	1.49	0.60	1.49	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	156.82	132.79	115.08	6.32	3.79	2.53	1.26	0.00	3.79	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	87.13	80.53	65.35	7.26	2.64	0.00	0.00	5.94	2.64	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	128.33	107.86	93.24	4.87	2.60	1.95	0.97	0.32	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	126.21	131.55	116.02	5.34	0.97	0.49	0.97	1.94	1.94	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	97.99	92.65	80.77	3.56	1.78	1.19	0.00	1.78	4.75	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	158.19	106.21	82.48	4.52	2.26	1.88	0.00	1.51	0.75	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	132.80	117.56	94.34	3.63	0.00	2.18	0.73	2.18	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	81.50	104.06	94.03	2.51	1.25	0.00	0.00	10.03	6.27	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	120.59	148.59	138.87	5.27	2.80	1.98	1.81	0.82	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	147.40	116.01	91.44	4.09	2.73	2.73	1.36	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	115.20	98.62	93.64	3.92	1.21	2.71	1.06	1.66	0.75	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	153.24	117.87	93.76	4.29	2.68	1.07	2.68	3.21	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	145.10	97.30	75.95	4.16	2.65	0.94	1.32	2.46	1.13	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	124.82	103.44	79.65	3.74	2.94	2.41	0.80	1.60	2.41	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	140.47	103.40	52.67	2.93	2.93	0.00	0.98	4.88	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	160.05	110.46	101.51	4.64	2.32	1.33	0.50	1.99	0.50	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	85.25	88.85	79.25	0.00	3.60	1.20	0.00	3.60	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	194.71	102.66	127.45	0.00	0.00	0.00	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	147.17	113.90	92.80	4.63	2.92	2.57	1.03	1.37	1.37	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	88.09	75.51	58.73	4.19	8.39	0.00	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	165.53	125.24	104.37	3.40	2.43	0.49	1.46	1.94	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	148.74	127.12	114.59	6.45	3.42	0.76	0.00	2.28	2.66	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	102.97	89.64	62.99	2.42	3.63	1.21	3.63	9.69	1.21	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	147.64	121.99	98.62	3.42	2.85	1.14	0.57	2.28	1.14	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	124.42	100.05	77.81	6.41	2.57	0.86	1.07	1.50	0.43	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	121.56	76.14	62.46	3.36	1.03	1.03	2.58	2.84	1.03	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	141.70	148.74	119.18	3.28	2.35	2.82	1.88	2.35	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	136.66	97.11	82.64	4.18	3.86	3.22	1.61	2.25	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	104.88	73.49	62.78	0.71	2.14	0.00	0.00	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	144.48	116.99	96.52	8.19	1.17	1.75	1.17	2.34	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	143.31	104.77	88.82	3.91	2.41	1.81	0.90	2.11	1.81	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	122.36	62.96	80.78	2.38	1.19	0.00	1.19	2.38	1.19	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	167.82	124.60	126.63	4.07	2.03	1.53	3.56	1.02	1.02	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	145.68	107.48	91.69	4.58	1.53	0.76	0.76	3.06	3.06	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	91.49	90.22	67.35	5.72	4.45	0.00	1.27	2.54	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	150.61	138.09	130.75	5.61	4.32	2.16	2.16	3.45	2.16	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	175.91	122.99	94.62	3.18	2.96	1.69	1.48	1.69	1.69	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	117.73	86.99	77.43	3.77	1.45	2.03	0.29	2.32	2.61	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	152.10	119.98	103.92	7.56	4.72	0.94	2.83	4.72	0.94	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	154.44	127.65	97.31	6.61	4.24	0.85	1.02	3.05	1.19	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	101.92	115.82	76.44	6.95	0.00	0.00	0.00	2.32	4.63	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	196.47	143.65	126.75	8.45	2.11	2.11	4.23	4.23	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	168.96	118.36	101.85	6.65	2.14	1.72	1.29	2.57	0.43	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	140.19	98.67	90.85	6.02	1.80	1.80	1.80	2.41	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	180.79	115.18	111.53	5.10	1.46	0.73	2.92	2.92	0.73	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	175.86	140.46	128.96	5.98	3.68	1.15	1.38	2.07	1.15	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	102.01	91.81	68.86	5.10	0.00	2.55	0.00	2.55	5.10	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	188.64	119.23	136.78	8.14	4.07	0.76	0.51	1.27	0.76	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	188.48	146.98	120.77	6.19	2.89	2.27	1.45	2.89	1.03	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	127.30	89.66	85.07	7.04	1.84	1.53	1.84	3.67	0.31	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	180.69	142.45	127.15	5.26	2.39	3.35	2.39	4.78	1.43	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	139.92	113.53	88.03	4.66	2.22	2.44	0.89	2.22	2.00	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	94.60	86.97	93.07	1.53	3.05	3.05	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	158.97	114.10	115.21	4.98	3.88	1.11	0.55	1.66	2.22	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	148.81	103.53	89.77	4.77	1.85	1.32	1.06	2.38	1.59	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	118.12	88.32	94.13	5.09	2.18	1.45	1.09	3.27	0.73	1.82
Astrocyte - cerebellum, donor1	11500-119F6	371.15	212.72	194.54	2.95	1.84	0.74	1.23	0.98	0.61	0.25
Astrocyte - cerebellum, donor2	11580-120F5	204.54	111.43	55.80	3.25	1.54	0.17	1.03	0.51	0.17	0.51
Astrocyte - cerebellum, donor3	11661-122F5	121.65	37.13	21.81	0.42	0.42	0.21	0.00	0.21	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	57.52	96.56	85.75	0.00	0.70	0.35	0.35	0.35	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	103.37	170.35	119.71	2.59	2.10	0.32	1.62	1.29	0.65	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	73.54	100.53	57.58	2.39	0.60	0.15	0.75	0.30	0.75	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	10.67	0.00	0.11	0.92	0.34	2.75	0.34	0.00	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	10.02	0.50	0.00	1.88	0.13	2.88	0.13	0.13	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	11.04	0.00	0.11	1.48	0.00	3.87	0.00	0.11	0.00	0.00
Basophils, donor1	12241-129G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	15.58	10.00	4.70	0.73	0.15	0.00	0.15	0.15	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	159.55	88.40	44.41	0.65	0.43	1.08	0.00	0.22	0.65	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	75.89	33.37	9.60	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	423.24	430.41	50.21	7.17	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	86.62	172.60	151.89	1.88	2.51	0.00	0.63	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	60.51	101.48	81.52	1.25	0.62	0.42	0.83	0.21	0.00	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	42.14	59.88	28.79	1.38	0.00	0.00	0.46	0.00	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	238.25	259.66	72.34	1.80	1.08	0.90	0.54	4.14	1.26	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.93	0.00	0.00	0.00	0.00	0.00	0.23	0.00	0.47	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	2.25	0.56	2.82	0.56	0.56	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	0.44	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	0.14	0.00	0.00	0.00	0.00	0.14	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.65	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.89	0.00	0.00	0.15	0.00	0.00	0.00	0.00	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.00	0.00	0.00	0.35	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	4.91	4.09	0.00	0.00	0.00	0.00	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.46	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.00	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	0.00	0.00	2.03	0.00	2.03	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	2.03	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	2.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	4.80	0.00	0.00	0.00	0.00	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	2.68	0.00	0.00	0.00	0.00	0.54	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	2.81	0.00	0.70	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1.57	0.00	0.00	1.57	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	3.95	1.32	1.32	0.00	0.00	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	1.45	0.00	0.00	0.73	0.00	0.73	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	0.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1.80	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.00	0.00	0.00	0.00	0.00	0.16	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.45	0.00	0.00	0.00	0.00	0.00	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.00	0.00	0.00	0.00	0.25	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.36	0.36	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	131.21	0.00	0.00	7.34	0.46	13.53	2.98	0.69	0.46	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	116.23	0.00	0.00	4.79	0.96	9.35	0.96	0.48	1.44	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	100.68	0.00	0.00	3.01	0.82	11.49	1.64	1.92	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	209.55	0.00	0.00	5.70	1.80	20.41	3.00	0.30	0.60	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	151.91	0.00	0.00	5.52	1.68	10.56	0.96	0.72	0.72	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	146.89	0.00	0.00	5.23	0.23	11.60	1.59	0.45	0.23	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	114.51	0.00	0.00	5.87	0.65	13.25	1.52	0.43	0.22	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	137.13	0.00	0.00	4.74	1.58	15.79	1.84	0.53	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	104.12	0.00	0.00	7.97	1.88	11.49	0.94	0.23	0.23	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	109.88	0.00	0.00	6.64	1.51	13.28	0.60	0.91	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	81.92	0.00	0.00	5.81	0.87	8.72	1.45	0.58	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	125.22	0.00	0.00	10.92	0.27	14.12	2.13	0.27	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	323.06	0.00	0.00	10.07	0.88	15.32	0.88	2.19	0.00	2.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	292.84	0.00	0.00	7.74	0.91	17.31	1.82	1.82	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	676.51	0.00	0.00	8.20	1.49	17.90	2.24	0.75	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	230.50	0.00	0.00	4.32	0.36	15.13	1.44	0.72	0.00	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	207.45	0.00	0.00	4.60	0.58	13.52	1.15	1.15	0.29	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	155.09	0.00	0.00	6.13	0.47	11.78	0.47	0.47	0.47	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	154.65	0.00	0.00	7.61	1.58	17.11	1.58	0.63	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	152.24	0.00	0.00	7.69	1.23	11.07	0.31	1.54	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	132.72	0.00	0.00	5.77	1.28	11.22	1.60	0.64	0.64	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	126.98	0.00	0.00	8.41	0.76	9.56	0.76	1.53	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	115.87	0.00	0.00	3.55	1.18	14.19	1.18	0.79	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	86.99	0.00	0.00	1.51	0.00	8.32	0.76	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	300.31	0.00	0.00	14.45	4.01	33.72	2.41	2.41	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	287.47	0.00	0.00	9.79	0.70	31.47	2.10	2.80	0.00	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	394.69	0.00	0.00	19.03	5.01	49.09	3.01	2.00	0.00	3.01
Cardiac Myocyte, donor1	11525-119I4	118.80	133.42	27.42	7.31	10.97	0.00	1.83	3.66	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	64.23	21.25	6.42	0.49	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	126.49	142.48	103.86	2.21	4.10	1.05	1.05	0.42	0.42	0.00
Chondrocyte - de diff, donor1	11261-116G1	500.24	141.79	73.49	7.63	10.05	1.73	3.12	1.73	2.77	2.43
Chondrocyte - de diff, donor2	11338-117F6	211.45	39.09	17.77	2.49	7.82	2.13	0.36	0.71	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	185.23	64.63	25.03	5.35	8.99	1.82	0.80	1.48	1.25	1.48
Chondrocyte - re diff, donor2	11339-117F7	118.17	9.85	9.85	5.37	3.58	2.69	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	51.36	13.75	6.87	3.64	3.24	0.40	0.40	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	285.17	431.15	383.41	3.56	1.15	0.92	1.26	2.30	1.03	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	94.27	120.35	67.98	2.57	1.28	0.43	0.64	1.71	1.07	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	95.22	128.94	75.75	1.77	0.44	0.18	0.88	1.15	0.53	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	226.41	47.68	76.85	9.90	5.87	1.01	13.39	0.00	0.73	0.28
Corneal Epithelial Cells, donor1	11526-119I5	84.54	76.85	37.33	1.76	0.22	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	79.63	58.02	17.06	0.00	0.00	0.00	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	99.70	76.69	48.06	0.26	0.26	0.77	0.00	0.77	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	0.33	0.00	0.00	0.00	0.00	0.17	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	153.26	213.30	481.96	2.33	0.67	0.33	0.67	0.33	1.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	165.47	213.00	261.12	1.76	0.59	0.00	0.59	1.17	1.76	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	202.20	272.90	546.93	1.13	1.13	0.00	0.57	1.70	1.98	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	123.46	234.73	374.70	1.57	1.57	0.39	2.36	1.57	0.79	0.39
Endothelial Cells - Artery, donor1	11264-116G4	91.92	178.60	292.04	1.45	0.29	0.00	0.29	1.16	0.58	0.87
Endothelial Cells - Artery, donor2	11341-117F9	106.35	207.75	360.92	2.82	0.47	0.00	1.18	0.94	1.65	1.65
Endothelial Cells - Artery, donor3	11413-118E9	80.12	190.04	268.22	1.40	1.05	0.70	0.00	0.35	0.88	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	133.21	641.02	1442.74	1.11	1.55	0.00	0.89	4.43	5.32	3.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	187.43	687.95	1396.28	4.26	1.22	0.30	0.30	4.26	4.26	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	157.87	729.28	1543.70	3.95	0.56	0.28	0.28	1.69	4.23	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	134.90	346.46	782.95	3.57	0.30	1.78	0.89	1.78	1.49	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	134.33	236.38	385.81	0.52	0.52	0.00	0.00	2.60	1.04	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	81.10	229.41	495.40	2.13	1.42	0.14	0.43	2.13	2.13	2.41
Endothelial Cells - Thoracic, donor1	11266-116G6	310.49	537.76	1158.35	2.00	1.20	1.60	1.20	3.60	4.00	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	81.76	95.91	187.64	2.10	0.00	1.57	0.00	0.52	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	150.46	760.39	1515.43	2.73	0.99	0.87	0.62	3.11	4.22	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	106.24	247.90	388.46	0.65	0.87	0.22	0.22	3.48	0.65	2.82
Endothelial Cells - Umbilical vein, donor3	11400-118D5	143.87	281.02	445.52	2.32	0.61	0.37	0.61	3.30	1.34	2.44
Endothelial Cells - Vein, donor1	11267-116G7	61.43	126.26	205.89	2.28	0.00	0.00	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	112.46	138.30	240.98	1.40	0.00	0.00	0.70	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	76.31	174.43	296.43	1.10	1.26	0.16	0.79	1.73	0.79	0.94
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	201.57	107.26	55.46	0.73	0.49	0.49	0.49	0.49	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	70.73	20.80	0.00	2.08	0.00	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	227.76	260.30	81.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	664.21	89.49	59.11	10.26	7.39	2.46	0.82	3.28	1.64	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	208.47	79.05	64.49	4.27	7.99	1.09	1.53	6.68	7.01	3.39
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	119.71	60.89	28.49	3.14	4.88	0.87	0.98	3.58	2.60	3.36
Fibroblast - Aortic Adventitial, donor1	11245-116E3	168.70	101.27	88.05	4.37	5.82	1.46	1.82	1.21	0.97	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	227.50	95.53	90.34	6.00	6.96	1.36	0.96	0.14	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	151.45	67.50	36.49	4.54	6.54	1.37	1.27	1.16	0.84	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	145.18	116.20	61.39	2.37	4.48	1.05	0.53	1.32	1.05	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	247.16	149.16	99.33	3.99	4.32	2.66	1.66	1.66	2.33	2.99
Fibroblast - Cardiac, donor1	11268-116G8	185.08	39.47	21.77	2.72	2.72	0.91	0.00	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	50.78	21.22	15.16	0.00	3.03	0.76	0.76	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	67.50	29.49	21.45	2.21	2.68	1.42	0.16	0.16	0.32	0.32
Fibroblast - Cardiac, donor4	11452-119A3	193.38	139.73	81.84	4.24	6.97	1.52	0.61	0.30	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	48.86	60.53	54.44	2.41	1.14	0.00	0.51	0.51	0.63	0.51
Fibroblast - Cardiac, donor6	11460-119B2	89.14	93.23	68.52	1.67	1.21	0.30	0.30	0.76	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	152.62	70.08	42.07	2.01	0.67	0.13	0.13	0.00	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	154.88	108.72	35.81	0.43	1.73	0.00	0.00	1.73	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	114.25	82.03	26.37	2.93	0.00	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	166.98	44.28	25.83	3.00	0.23	0.69	0.23	0.00	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	247.62	258.48	72.76	2.71	3.73	0.34	0.51	1.02	1.02	0.34
Fibroblast - Dermal, donor1	11269-116G9	460.88	304.98	182.19	4.70	3.52	0.70	0.94	3.29	2.35	5.63
Fibroblast - Dermal, donor2	11346-117G5	540.54	281.59	253.29	4.72	2.36	0.47	0.94	0.94	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	486.08	316.72	203.93	5.56	4.35	0.48	0.48	5.08	3.02	5.44
Fibroblast - Dermal, donor4	11450-119A1	675.79	414.42	225.19	3.50	2.26	0.45	2.15	1.58	2.15	1.13
Fibroblast - Dermal, donor5	11454-119A5	758.17	517.43	281.22	4.36	5.23	0.17	3.49	2.79	1.57	1.92
Fibroblast - Dermal, donor6	11458-119A9	1078.82	635.73	355.71	4.39	2.27	1.30	3.57	2.11	3.90	2.60
Fibroblast - Gingival, donor1	11237-116D4	677.16	508.08	355.45	7.08	4.58	1.67	1.87	0.62	1.46	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	886.87	275.10	180.52	23.06	12.84	3.67	2.88	7.60	3.14	4.72
Fibroblast - Gingival, donor2	11318-117D4	550.33	382.31	211.25	5.80	3.82	0.92	3.03	3.69	2.90	2.37
Fibroblast - Gingival, donor3	11394-118C8	309.59	225.38	83.63	4.93	5.99	0.97	1.26	0.39	0.77	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	381.27	89.34	60.26	5.19	2.08	1.04	3.12	0.00	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	246.51	41.76	19.38	3.00	4.05	1.06	0.18	2.64	0.53	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	1232.67	320.21	255.67	11.69	10.76	1.56	3.90	11.54	4.21	6.24
Fibroblast - Gingival, donor6 (control)	11922-125H5	1088.58	371.33	261.39	10.55	9.74	2.57	4.60	10.95	2.98	5.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	834.56	193.03	179.62	9.88	4.23	1.41	1.41	0.71	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	1292.07	384.48	249.35	10.24	14.92	2.34	4.97	16.96	3.95	8.19
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	1486.80	508.73	403.33	12.68	16.50	1.64	5.86	17.86	3.55	11.32
Fibroblast - Gingival, donor8 (control)	11926-125H9	782.66	272.37	186.26	8.45	9.43	1.65	5.59	7.35	1.86	3.51
Fibroblast - Gingival, donor9 (control)	11927-125I1	172.56	67.94	26.71	2.35	5.43	1.32	0.59	1.76	1.91	1.03
Fibroblast - Lung, donor1	11270-116H1	154.97	76.12	24.47	1.36	0.00	0.00	1.36	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	499.87	256.65	156.68	5.97	0.00	0.00	2.98	1.49	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	325.84	146.88	78.29	3.38	4.01	0.84	2.53	2.95	1.69	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	1065.43	210.75	141.61	5.00	1.67	2.50	2.50	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	440.57	124.48	61.54	2.80	4.20	1.40	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	133.50	26.87	5.60	0.84	0.28	0.00	0.28	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	1208.16	287.83	174.16	6.50	3.65	1.62	1.22	0.41	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	563.18	59.91	27.96	3.99	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	476.50	196.56	119.13	0.00	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	548.17	357.69	222.68	6.98	2.52	1.36	2.13	2.13	2.52	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	525.27	370.26	162.60	4.55	2.12	0.61	2.58	1.06	1.82	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1077.08	742.33	631.86	14.08	6.73	1.84	2.14	1.53	2.75	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	832.32	150.36	65.64	4.58	6.11	1.14	3.05	2.67	1.91	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	451.96	125.01	75.60	5.13	3.78	1.35	2.70	2.97	1.89	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	296.89	55.90	27.95	6.49	5.22	1.16	1.86	0.81	0.58	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	109.43	138.28	110.20	2.43	2.43	1.33	1.22	0.44	0.44	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	507.16	83.71	54.86	7.72	1.02	0.61	0.20	0.61	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	466.41	172.40	98.23	0.00	2.00	0.00	0.67	0.67	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	415.52	468.11	206.38	3.56	2.77	1.58	0.00	5.54	1.19	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	423.49	250.24	152.01	4.56	4.37	1.19	2.18	3.97	2.58	9.33
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	514.20	151.15	101.06	9.59	12.43	2.13	1.60	1.95	3.02	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	912.11	213.64	139.34	5.72	13.01	2.37	1.77	2.17	2.76	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	585.16	213.01	125.46	7.82	6.62	1.81	4.21	2.41	1.20	4.21
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1076.60	307.12	261.03	8.96	12.41	2.37	2.91	1.40	3.24	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	285.47	183.73	113.12	5.06	4.30	1.27	1.27	2.28	2.28	2.02
Fibroblast - skin normal, donor1	11553-120C5	724.08	311.42	190.33	10.01	8.37	4.10	1.48	2.30	2.79	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	463.37	172.24	142.96	4.81	5.01	1.20	1.80	0.60	1.60	0.80
Fibroblast - skin normal, donor2	11561-120D4	309.12	148.88	132.21	5.42	9.74	3.42	1.21	0.40	0.80	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	532.84	239.07	149.00	4.23	6.65	1.81	2.72	2.42	3.32	8.16
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	604.44	198.66	124.35	8.04	15.00	1.57	1.08	1.24	1.57	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	453.53	140.86	73.85	6.33	3.93	1.37	0.85	0.68	1.03	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	597.09	228.26	131.37	4.93	8.54	1.31	1.64	0.99	1.64	5.25
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	735.53	292.62	270.67	11.18	9.16	2.98	3.20	0.96	2.66	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	836.99	242.23	190.27	7.42	5.06	1.18	2.53	1.52	1.86	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	401.46	239.31	201.20	2.67	5.02	2.51	0.94	19.45	7.68	5.65
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1174.47	864.23	975.03	0.00	0.00	22.16	22.16	22.16	0.00	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	46.19	25.27	10.46	0.87	1.74	0.00	0.00	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	99.51	246.69	281.19	4.51	1.73	2.25	0.87	1.21	1.73	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	117.11	326.86	359.13	5.47	0.78	1.82	0.52	4.16	3.12	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	212.59	399.37	562.64	3.83	2.04	1.79	0.51	2.56	1.02	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	30.62	4.59	3.83	1.53	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	38.92	9.57	4.47	0.00	0.64	0.00	1.91	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	25.96	6.28	2.57	0.29	0.00	0.57	0.57	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	2.21	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	3.65	1.37	0.00	0.00	0.00	0.00	0.46	0.68	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	24.57	2.38	1.78	0.99	0.00	0.40	0.00	0.59	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	3.70	1.06	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	2.94	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	18.13	3.10	1.77	0.44	0.00	0.00	0.00	0.44	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	6.64	1.41	0.42	0.28	0.14	0.14	0.14	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	14.16	1.85	1.60	0.86	0.00	0.00	0.12	0.12	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	8.60	1.88	2.15	0.54	0.27	0.27	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	61.20	6.07	4.83	5.45	0.25	1.98	0.74	1.12	0.25	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	79.46	9.14	6.09	7.48	0.14	2.08	1.25	0.97	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	57.74	5.69	4.07	4.47	0.61	1.42	0.81	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	45.86	18.94	9.81	1.83	0.91	0.91	0.46	0.46	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	51.57	18.06	7.60	3.86	0.25	0.62	0.75	0.75	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	41.75	11.15	5.03	3.50	0.00	1.09	0.66	0.44	0.44	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	33.98	8.57	6.21	0.00	0.00	0.00	0.59	0.30	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	39.10	10.49	6.52	1.43	0.16	0.48	0.16	0.00	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	16.53	8.27	4.47	1.12	0.22	0.67	0.45	0.00	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	51.42	9.48	4.03	0.20	0.00	0.20	0.20	0.40	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	57.51	7.46	6.79	1.70	0.17	0.34	0.51	0.51	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	40.79	15.52	11.00	1.15	0.09	0.35	0.53	0.09	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	56.61	12.59	6.87	0.94	0.00	0.00	0.21	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	68.99	9.91	6.15	0.17	0.17	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	46.59	6.86	5.53	0.33	0.22	0.00	0.00	0.11	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.61	9.82	6.57	0.83	0.08	0.42	0.25	0.17	0.25	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.24	9.39	6.53	1.02	0.00	0.61	0.41	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	44.56	10.11	4.33	0.62	0.00	1.03	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	43.35	7.84	3.92	0.35	0.00	0.23	0.12	0.23	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	34.52	7.50	4.50	0.67	0.00	0.33	0.33	0.17	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	41.44	10.80	3.53	0.44	0.00	0.00	0.00	0.22	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	35.91	9.59	4.30	0.25	0.25	0.37	0.00	0.49	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	22.37	4.86	3.57	0.49	0.00	0.00	0.16	0.00	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	27.90	6.74	3.53	0.00	0.00	0.00	0.00	0.64	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	39.32	8.72	5.02	0.47	0.19	0.09	0.19	0.09	0.00	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	46.50	7.28	3.64	0.16	0.16	0.32	0.32	0.00	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	43.48	6.39	3.95	0.30	0.00	0.00	0.00	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	45.79	6.79	4.91	0.21	0.10	0.10	0.00	0.31	0.21	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	34.47	9.44	5.71	0.00	0.22	0.00	0.00	0.00	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	35.07	10.38	5.61	0.28	0.28	0.28	0.00	0.28	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.85	12.31	10.55	0.37	0.09	0.19	0.19	0.28	0.09	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	41.18	11.77	6.42	0.27	0.00	0.27	0.27	0.00	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	51.26	8.57	6.73	0.77	0.31	0.00	0.31	0.46	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	63.47	19.56	13.34	0.39	0.13	0.13	0.13	0.39	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	37.41	11.11	4.07	0.00	0.00	0.00	0.00	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	73.00	42.77	24.33	1.47	0.37	0.37	0.18	0.74	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	76.54	45.18	28.07	1.54	0.22	0.22	0.66	0.22	1.10	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	45.62	22.81	10.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	106.72	87.19	52.24	1.98	0.66	0.13	0.40	0.79	0.66	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	96.84	90.39	43.58	2.02	0.00	0.40	0.20	1.61	0.81	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	45.24	38.89	17.03	1.02	0.51	0.25	0.00	0.25	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	6.77	1.59	1.19	0.20	0.00	0.20	0.00	0.20	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	2.31	0.46	0.15	0.31	0.15	0.00	0.00	0.15	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4.71	2.05	1.02	0.20	0.00	0.20	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	13.46	6.88	2.82	0.63	0.00	0.00	0.63	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	10.45	10.74	3.39	0.57	0.00	0.28	0.57	0.28	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	11.07	3.23	2.31	1.38	0.92	0.00	0.00	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	7.42	2.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	11.99	3.87	1.16	1.16	0.00	0.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	19.25	3.21	1.60	0.00	0.00	0.00	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1.30	0.33	0.33	0.33	0.00	0.33	0.00	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	5.35	2.06	1.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	2.52	0.28	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	2.94	1.31	0.98	0.33	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	0.64	0.32	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	2.04	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	2.09	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	2.29	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	2.66	0.30	0.59	0.30	0.00	0.30	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	3.73	0.83	0.41	0.00	0.00	0.41	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	3.22	0.23	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	5.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	4.01	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	2.70	0.39	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	10.95	0.34	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	5.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	6.03	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	1.53	0.00	0.51	0.00	0.00	0.51	0.00	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	2.39	0.40	0.80	0.00	0.00	0.00	0.00	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	3.45	1.97	0.00	0.00	0.00	0.00	0.00	0.00	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	1.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	2.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	1.32	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	0.85	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	7.76	1.19	1.19	0.00	0.00	0.00	0.00	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	2.43	0.00	0.00	0.00	0.00	0.00	0.00	0.49	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	631.14	283.04	212.28	11.41	1.14	2.28	1.14	1.14	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	419.97	234.52	164.66	6.24	2.08	0.00	2.49	1.25	3.74	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	241.76	170.92	132.69	4.50	1.12	1.12	1.12	0.00	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	255.00	299.40	101.17	13.32	6.66	0.95	0.63	2.85	0.63	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	347.56	407.30	160.83	8.77	10.44	1.25	0.00	3.76	2.09	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	139.02	20.42	13.81	4.76	2.09	1.28	1.97	0.93	0.58	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	164.41	18.40	11.98	6.75	2.53	2.03	2.19	0.68	0.68	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	134.00	10.24	6.14	4.78	2.05	0.68	0.91	0.23	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	135.32	21.64	13.12	3.83	2.73	2.08	1.42	0.44	0.66	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	154.31	23.21	12.68	4.94	3.01	0.86	1.93	0.21	0.00	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	124.00	9.04	6.46	3.01	1.94	1.72	1.51	0.43	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	109.72	15.32	9.09	3.61	2.62	0.75	1.87	0.50	0.12	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	124.03	15.10	7.89	2.74	1.54	1.37	1.72	0.34	0.69	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	93.23	8.65	4.16	1.60	1.28	1.60	0.64	0.00	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	83.38	141.58	226.65	1.12	0.00	1.12	0.00	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	171.82	22.94	15.15	2.16	0.87	0.00	0.00	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	296.11	399.21	417.72	2.64	0.00	0.00	0.00	7.93	5.29	15.86
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	190.12	60.32	25.40	2.82	2.12	0.35	0.71	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	82.10	22.52	8.72	0.00	0.00	0.73	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	145.47	136.90	85.85	0.87	2.27	0.52	0.87	0.52	0.35	0.87
Hepatocyte, donor1	11523-119I2	1.21	0.00	0.00	0.00	1.21	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	3.23	0.00	0.00	0.00	0.00	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	20.25	4.91	7.36	0.61	0.61	0.61	0.00	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	3.85	2.45	0.17	0.35	0.17	0.35	0.00	0.35	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	184.13	224.06	148.18	2.20	1.92	0.27	0.69	0.41	1.51	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	2.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	2.44	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.91	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.09	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.87	1.74	1.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	2.13	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	192.41	560.42	566.87	1.96	0.73	0.08	0.57	2.20	2.77	0.82
Keratinocyte - epidermal, donor2	11349-117G8	53.88	111.27	67.93	1.17	0.59	0.59	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	184.58	343.79	251.41	1.80	0.85	0.38	0.47	4.64	2.18	5.49
Keratinocyte - oral, donor1	11251-116E9	274.49	831.29	403.78	4.20	1.25	1.02	0.57	1.25	1.14	1.02
Keratocytes, donor1	11527-119I6	96.62	44.35	11.69	1.38	0.34	0.00	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	529.65	93.74	57.42	2.34	0.00	0.00	1.17	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	35.77	45.25	9.88	1.19	0.79	0.40	0.00	0.40	0.20	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	79.12	6.59	2.20	2.20	0.00	0.00	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	206.04	253.50	125.13	2.16	2.16	2.16	0.00	4.31	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	141.97	400.32	372.64	4.15	0.92	0.81	0.23	1.27	0.81	0.69
Lens Epithelial Cells, donor3	11690-122I7	166.40	102.83	76.99	5.35	2.52	1.61	1.11	0.50	0.30	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	76.01	421.42	585.18	5.10	0.47	3.32	0.47	1.78	1.90	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	32.93	306.70	401.03	3.35	0.56	1.67	0.00	5.58	3.91	2.79
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	78.39	419.19	520.25	6.93	1.57	4.09	0.47	4.56	4.09	4.25
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	83.35	275.31	353.28	2.69	1.61	0.54	1.08	4.30	2.15	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	33.41	216.83	284.91	3.15	0.63	1.26	0.32	4.41	3.78	4.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	47.98	221.34	270.18	3.13	0.54	1.40	0.22	2.26	1.08	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	62.79	325.03	359.91	5.75	1.64	2.05	0.00	4.10	4.10	2.87
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.27	175.20	216.92	2.28	0.25	1.01	0.25	1.77	1.26	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	56.44	262.36	315.84	4.22	0.28	1.41	0.00	2.39	1.69	2.67
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	78.32	285.97	375.76	1.98	1.19	1.58	0.00	2.77	1.58	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	32.57	267.75	323.20	2.52	0.78	1.16	0.19	5.04	1.74	2.71
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	31.85	142.93	164.78	2.78	0.19	0.74	0.19	1.11	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	54.35	297.90	432.39	4.18	0.35	0.35	1.05	3.14	0.70	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	32.44	269.29	315.09	4.29	0.95	2.39	0.00	2.62	1.19	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	53.15	223.47	262.06	3.16	0.82	1.65	0.55	1.37	1.51	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	71.45	237.74	315.97	3.70	1.23	0.92	0.62	6.16	4.00	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	26.50	180.50	230.38	2.81	0.31	0.31	0.94	1.25	1.25	1.56
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	50.51	223.43	254.72	3.48	0.37	2.01	0.00	1.65	1.28	1.83
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	60.89	319.90	366.96	3.95	0.66	1.32	0.00	2.96	1.65	2.30
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	23.14	181.29	196.52	3.51	0.00	1.46	0.00	0.59	1.76	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	43.06	164.79	195.66	2.99	1.00	1.24	0.50	0.75	0.50	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	74.68	340.93	435.50	4.36	0.48	1.94	0.48	4.36	2.42	3.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	38.51	270.37	371.36	5.39	0.54	2.15	0.54	3.77	2.69	2.15
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	68.42	236.45	290.49	4.24	0.45	2.27	0.30	0.61	1.82	1.97
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	73.61	244.17	310.53	3.63	1.56	2.59	0.52	4.15	2.59	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	46.69	277.86	344.24	3.77	0.21	0.63	0.21	5.65	2.72	4.82
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	67.52	195.93	237.29	3.46	0.75	2.26	0.15	2.71	1.35	1.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	96.99	251.76	314.36	5.50	0.00	1.38	0.00	1.38	2.75	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	39.89	211.86	277.14	3.20	0.38	2.82	0.56	2.26	0.75	2.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	45.17	141.44	190.54	3.18	0.21	1.38	0.11	1.06	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	82.86	229.21	306.74	3.88	0.97	1.45	0.00	6.30	3.88	3.39
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	42.67	193.51	237.84	1.65	0.66	0.33	0.33	2.98	1.32	1.98
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	56.25	159.20	210.74	2.97	0.62	1.73	0.12	0.74	1.12	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	97.37	251.00	364.66	10.37	1.11	1.48	0.74	4.44	2.22	3.33
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	41.26	249.06	323.68	3.21	0.49	1.48	0.49	4.69	0.49	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	57.47	182.87	221.36	3.02	0.27	1.51	0.55	1.51	1.51	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	77.51	297.52	403.98	2.89	0.32	3.22	0.64	3.54	0.96	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	52.95	296.72	391.06	4.87	0.91	2.74	0.91	3.35	3.65	2.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	86.64	304.15	425.50	5.04	0.84	1.54	0.28	2.38	1.54	2.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	73.25	295.12	461.87	4.27	0.36	2.84	0.36	6.76	1.07	2.13
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	32.96	167.73	211.36	3.88	0.00	0.48	0.00	1.94	0.97	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	39.37	111.57	144.09	2.80	0.31	1.40	0.00	1.09	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	66.61	217.01	303.32	2.51	0.72	1.79	0.36	2.51	1.43	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	42.47	188.49	240.43	1.63	0.33	0.65	0.00	1.96	1.63	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	45.91	106.65	137.49	1.65	0.71	0.47	0.00	2.12	0.94	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	106.30	279.31	482.26	5.82	1.24	2.72	0.74	1.11	1.73	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	33.30	115.00	157.01	1.54	0.00	0.77	0.26	1.28	1.02	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	60.27	138.14	163.50	2.09	0.60	0.90	0.00	1.19	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	126.90	29.46	15.86	2.27	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	207.13	35.29	19.95	6.14	2.30	1.53	3.07	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	220.44	32.66	19.30	5.94	2.97	0.74	0.00	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	242.45	44.01	17.77	3.81	0.85	2.96	1.27	1.69	0.42	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	189.90	31.65	19.69	5.63	1.41	2.81	0.00	3.52	3.52	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	201.74	52.30	14.94	8.41	1.87	0.00	0.93	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	233.93	46.89	17.52	5.67	0.52	0.00	1.03	2.06	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	221.24	34.49	7.14	8.33	3.57	0.00	0.00	2.38	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	181.41	45.01	32.35	6.11	0.23	2.49	0.68	0.00	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	289.08	68.64	26.17	6.69	1.74	1.16	2.04	2.91	2.04	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	284.96	51.32	29.26	9.45	4.05	1.35	1.35	4.95	1.80	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	234.39	55.68	35.63	8.54	2.85	2.71	1.08	0.27	0.81	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	230.06	45.19	18.49	5.14	1.03	1.54	1.54	1.03	1.54	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	301.34	44.46	22.23	8.12	2.47	0.35	0.35	2.12	1.41	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	314.50	53.97	19.99	5.33	1.33	0.67	1.33	2.67	0.67	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	268.96	39.73	19.87	7.13	1.02	0.51	0.51	2.04	3.06	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	296.42	53.09	25.61	5.07	0.80	2.93	2.13	1.07	1.60	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	319.88	53.28	28.72	7.56	2.08	2.08	0.94	1.32	1.13	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	261.99	42.34	19.63	4.29	1.23	0.61	1.84	4.29	1.23	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	309.86	39.14	17.94	11.42	0.82	0.82	0.82	2.45	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	311.53	54.14	24.78	7.91	2.71	1.04	3.12	1.25	1.46	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	361.54	50.45	29.43	7.57	0.28	2.80	1.40	4.20	2.52	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	248.31	38.12	12.36	8.24	1.03	2.06	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	312.95	56.61	26.42	7.55	2.03	1.74	2.03	3.77	3.19	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	321.65	61.28	30.79	8.07	2.39	1.49	1.79	3.59	2.09	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	331.40	54.77	27.66	7.75	1.11	2.77	1.11	0.55	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	299.05	45.60	29.69	7.78	2.47	0.71	1.41	2.12	2.47	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	320.47	43.52	22.86	6.27	0.74	0.74	1.48	1.84	2.95	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	261.34	37.99	20.72	5.76	2.30	4.61	3.45	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	318.13	44.52	24.56	4.99	1.54	2.30	2.30	1.92	0.38	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	290.43	48.12	23.21	7.93	0.57	1.70	1.70	1.70	1.70	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	290.45	48.41	31.18	4.92	0.00	3.28	1.64	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	285.14	55.13	28.47	5.42	0.45	4.07	1.36	0.90	2.71	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	334.65	53.86	17.95	9.34	0.00	1.44	1.44	0.72	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	333.12	58.26	28.38	11.20	2.24	2.99	0.75	0.75	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	269.03	49.05	21.55	7.43	0.74	1.49	1.49	0.74	2.60	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	352.35	66.34	27.57	7.32	1.29	0.86	0.86	1.72	1.29	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	280.87	48.81	24.83	9.42	0.86	0.86	1.71	0.00	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	325.51	44.31	23.32	6.00	1.33	0.33	2.33	2.33	1.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	298.03	36.80	12.67	3.62	1.81	1.21	0.60	0.60	0.60	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	231.07	31.28	13.51	8.53	0.71	2.13	0.71	0.71	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	260.54	41.93	20.62	7.22	1.03	1.03	1.03	1.03	1.72	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	318.29	55.82	20.40	4.83	3.22	1.61	1.07	1.07	1.07	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	242.41	28.28	12.79	5.39	0.67	2.02	0.67	0.67	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	304.85	46.30	24.82	5.56	0.74	0.74	1.85	1.85	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	170.95	37.21	25.58	9.30	0.00	2.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	218.95	32.79	11.64	4.23	0.00	2.12	1.06	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	280.51	47.22	25.21	6.00	1.20	1.20	1.60	2.80	1.20	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	226.06	41.43	14.54	4.36	1.45	1.45	1.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	232.25	37.56	20.70	10.73	0.00	0.77	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	291.03	40.45	25.65	6.91	0.99	2.96	1.97	2.96	2.96	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	263.46	34.81	13.17	3.76	0.94	0.94	0.00	1.88	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	248.90	39.22	18.60	5.03	2.01	3.02	1.51	0.50	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	238.38	49.57	24.33	5.86	2.70	1.35	0.00	0.90	2.25	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	278.82	56.80	18.93	5.16	3.44	1.72	0.00	5.16	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	258.74	38.30	18.26	7.57	0.45	2.67	0.45	0.45	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	261.60	47.31	16.03	5.87	1.17	2.35	2.74	1.96	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	249.38	45.52	21.11	7.26	1.98	1.32	2.64	3.30	3.96	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	242.34	45.15	17.64	6.75	1.04	3.63	1.04	0.00	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	262.98	37.63	27.13	6.56	2.19	0.88	1.75	0.44	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	291.29	50.32	27.96	7.83	3.35	0.00	1.12	3.35	2.24	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	242.90	44.16	17.67	7.07	0.00	2.21	0.88	1.32	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	270.39	45.13	20.44	8.10	1.16	3.47	0.77	1.16	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	327.10	43.55	21.27	8.61	2.53	3.54	2.03	1.01	3.04	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	292.22	35.09	15.86	7.21	0.48	2.40	1.44	1.92	1.44	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	289.81	49.30	21.07	7.55	1.59	1.19	0.80	0.40	1.99	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	331.15	46.79	14.58	7.29	1.22	1.22	0.61	2.43	3.65	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	262.16	38.74	22.13	9.68	2.08	2.77	2.08	2.77	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	307.03	54.34	23.56	7.98	1.14	2.28	0.76	0.76	3.80	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	376.98	51.64	18.07	10.33	1.55	2.58	0.52	1.03	1.55	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	229.77	39.91	16.93	8.47	2.42	1.81	0.60	0.60	1.21	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	321.97	49.44	30.42	8.87	2.22	0.95	1.90	0.95	2.85	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	368.90	44.78	21.86	7.46	1.07	0.53	1.07	2.13	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	274.12	40.80	22.99	8.05	0.57	4.60	2.87	1.15	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	369.73	49.37	25.71	6.17	1.03	0.51	0.51	1.54	2.06	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	401.78	42.44	24.05	4.95	0.71	1.41	0.71	2.12	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	328.57	48.80	20.43	6.81	1.13	1.13	1.13	1.13	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	309.52	44.51	27.87	9.15	0.42	1.66	3.33	2.08	1.66	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	382.12	51.68	25.06	9.40	3.92	0.00	2.35	1.57	3.13	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	264.72	57.20	22.55	11.27	0.84	1.67	2.51	1.67	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	312.70	50.65	20.44	10.22	0.93	1.86	3.25	1.39	1.39	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	421.50	50.18	22.08	6.69	1.34	0.67	0.67	2.01	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	353.93	50.26	28.34	6.42	2.14	1.60	1.07	1.07	1.60	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	377.83	46.47	25.86	6.87	1.21	1.62	0.40	0.81	1.62	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	426.76	43.13	16.52	4.59	1.84	3.67	1.84	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	416.99	43.57	16.00	11.56	3.56	0.00	2.67	0.89	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	455.90	44.45	27.35	6.84	2.85	1.14	0.57	1.14	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	444.80	37.58	19.17	3.07	0.00	0.77	1.53	3.07	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	403.27	58.00	36.11	9.85	2.19	3.28	2.74	0.55	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	412.48	41.43	24.95	8.46	2.23	0.89	1.34	1.34	1.78	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	329.36	57.19	42.11	6.76	0.52	2.86	1.04	0.52	1.04	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	317.63	54.37	33.82	8.62	0.66	0.00	0.66	3.32	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	455.22	43.65	22.86	2.08	0.00	0.00	2.08	0.00	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	103.02	227.28	252.24	3.19	2.66	1.06	0.00	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	150.53	313.74	349.55	7.29	2.06	1.90	1.90	0.95	1.58	0.16
Mallassez-derived cells, donor3	11930-125I4	103.55	288.40	302.71	3.89	1.67	1.11	1.11	1.25	0.97	0.28
Mammary Epithelial Cell, donor1	11273-116H4	326.93	241.24	207.06	5.88	3.49	1.59	2.09	1.30	0.80	0.30
Mammary Epithelial Cell, donor2	11350-117G9	342.54	360.20	244.38	2.32	2.03	0.87	0.87	2.32	2.32	0.29
Mammary Epithelial Cell, donor3	11422-118F9	220.74	140.43	88.55	1.25	1.25	0.00	0.00	1.00	0.50	0.75
Mast cell - stimulated, donor1	11487-119E2	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	5.65	1.78	5.35	0.00	0.59	0.00	0.00	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	6.98	1.13	1.58	0.00	0.23	0.00	0.00	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	3.55	1.06	1.60	0.18	0.18	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	74.82	252.72	374.41	3.08	1.89	2.39	0.40	1.29	0.80	0.70
Melanocyte - dark, donor2	11582-120F7	51.91	33.22	14.88	1.04	1.04	0.69	0.69	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	50.49	5.00	2.17	0.00	0.00	0.00	0.07	0.14	0.14	0.14
Melanocyte - light, donor1	11274-116H5	25.62	1.18	0.94	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	45.73	4.09	1.36	0.68	0.68	0.68	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	65.04	26.88	15.61	1.73	0.00	0.87	0.00	0.87	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	106.00	32.07	19.26	0.52	0.31	0.00	0.00	0.42	0.31	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	44.11	3.23	2.42	0.00	0.00	0.00	0.00	0.00	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	106.07	7.77	3.75	0.00	0.00	0.00	0.00	0.00	0.00	0.27
Meningeal Cells, donor1	11493-119E8	500.95	202.47	162.64	6.08	0.50	0.62	0.50	0.12	0.87	0.00
Meningeal Cells, donor2	11573-120E7	226.68	63.38	34.33	3.96	0.00	0.44	0.00	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	597.65	555.68	448.01	5.38	1.14	1.22	1.47	1.63	1.87	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	283.16	272.61	165.39	2.57	2.00	0.29	2.00	1.43	2.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	139.27	23.75	17.31	3.12	2.11	0.60	0.50	0.10	0.50	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	103.82	48.62	17.08	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	476.17	95.50	54.94	0.00	2.62	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	539.64	332.25	255.47	4.31	1.44	0.72	2.87	10.76	7.18	5.74
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	443.87	118.59	92.97	6.35	4.24	2.12	3.60	1.06	1.48	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	626.30	143.25	94.50	6.53	3.02	1.01	3.02	2.51	2.51	5.03
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	584.98	128.56	65.05	2.64	0.88	0.66	1.54	0.22	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	387.21	63.56	41.64	0.73	0.00	0.00	4.38	1.46	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	552.22	102.92	56.06	1.64	0.61	0.61	0.41	2.66	0.41	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	193.77	214.41	76.59	2.49	3.19	0.42	0.69	0.69	1.39	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	37.17	12.27	5.58	0.37	0.37	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	38.29	97.50	35.53	1.32	1.71	0.66	0.00	0.26	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	17.21	8.01	0.89	0.00	0.00	0.30	0.00	0.00	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	9.34	4.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	113.99	35.22	18.57	1.28	0.64	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	670.96	476.37	439.16	6.03	2.13	0.71	2.13	1.42	2.48	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	24.71	68.17	30.65	0.94	1.56	0.94	0.00	0.00	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	104.50	41.36	18.14	0.73	0.00	0.73	0.00	1.45	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	115.35	12.46	5.04	1.06	3.71	0.53	0.53	0.80	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	82.58	11.51	10.51	2.00	2.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	59.26	6.72	3.97	0.58	2.17	0.00	0.14	0.29	0.00	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	1.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	0.42	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.09	0.00	0.00	0.00	0.00	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.28	0.00	0.00	0.00	0.00	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.00	0.00	0.00	0.00	0.00	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	587.49	224.48	188.94	5.60	6.03	3.88	2.80	0.86	1.72	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	269.15	79.44	31.36	5.75	8.88	1.05	2.09	1.57	1.57	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	902.44	103.46	56.07	4.67	6.67	0.67	1.33	6.67	1.33	4.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	765.04	65.11	42.99	4.59	8.35	0.00	2.50	9.18	2.92	4.59
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	991.97	194.51	159.72	1.52	3.80	1.33	3.23	16.92	4.56	8.75
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	3670.46	271.29	194.69	11.17	6.38	0.00	9.58	3.19	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	596.31	44.88	28.56	3.40	6.80	2.04	1.36	8.16	0.68	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	380.39	126.80	180.09	0.00	1.84	0.00	1.84	3.68	1.84	7.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	608.13	77.85	47.71	6.28	4.60	0.00	2.51	7.95	2.09	6.28
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	981.82	133.65	105.06	6.51	9.53	0.93	1.86	14.18	5.35	7.44
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	649.09	101.06	48.91	3.51	4.59	0.54	3.51	3.78	1.35	5.13
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	1027.22	128.66	52.77	4.63	6.73	0.42	2.94	5.26	1.68	4.41
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	668.08	322.91	178.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	877.56	221.87	126.57	8.93	9.93	1.49	2.48	10.92	4.96	5.96
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	280.96	61.17	35.46	1.35	5.95	0.81	1.08	8.39	3.52	7.31
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	796.33	145.08	89.09	7.25	7.03	0.23	2.49	14.73	6.57	9.97
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	405.97	44.25	23.68	2.29	3.92	0.16	0.98	5.72	1.80	2.94
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	658.85	83.84	33.17	1.46	4.37	0.73	1.64	3.46	1.09	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	654.03	90.17	41.37	10.08	9.02	0.53	1.06	6.37	5.83	9.55
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	785.20	87.64	39.62	6.00	14.41	0.60	1.20	7.80	3.00	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	357.06	74.82	38.72	0.98	2.63	0.33	1.64	14.11	3.61	7.88
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	704.16	66.35	33.99	6.50	6.34	0.49	2.60	9.92	3.90	6.99
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	628.80	52.21	21.69	1.94	4.59	1.23	0.88	2.82	0.35	1.59
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	313.64	35.86	17.58	3.52	10.55	0.70	1.41	6.33	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	473.04	60.68	28.50	3.22	8.27	0.92	0.92	8.27	4.14	5.52
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	353.80	45.63	15.42	1.93	5.78	0.64	0.96	5.46	1.61	2.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	559.75	104.50	97.60	3.79	4.14	0.34	1.03	41.04	12.07	16.21
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	465.23	83.44	126.42	0.00	5.06	0.00	0.00	7.59	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	494.36	28.74	16.93	2.45	4.68	0.67	0.89	2.45	0.22	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	284.10	31.33	16.51	2.54	6.35	0.00	0.42	10.16	2.96	6.35
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	415.37	60.76	33.47	1.19	4.27	0.71	0.47	17.33	4.27	8.07
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	354.99	42.50	14.59	3.43	5.15	0.86	0.00	5.58	2.15	3.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	920.83	216.67	234.72	0.00	36.11	9.03	0.00	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	334.89	39.32	15.33	2.67	4.67	0.33	1.33	4.67	2.00	3.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	662.32	32.91	9.92	4.51	2.71	0.90	1.80	2.25	0.90	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	212.68	28.17	11.90	1.59	5.56	0.00	0.79	5.56	2.38	3.57
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	608.26	93.79	46.43	2.79	15.79	1.86	0.93	18.57	3.71	9.29
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	214.16	35.57	17.03	0.38	2.27	0.38	1.51	5.68	1.89	4.92
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	498.61	48.23	34.22	9.45	8.15	1.63	0.98	9.12	3.58	6.19
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	245.78	17.43	5.67	2.18	1.31	0.00	0.00	2.18	0.87	2.18
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	822.71	54.73	19.90	2.71	4.98	1.36	1.36	3.17	0.90	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	352.76	39.69	13.23	2.65	7.06	0.00	1.76	5.29	0.00	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	391.59	51.19	23.93	3.32	5.98	0.00	0.66	7.98	2.66	4.65
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	289.19	36.21	14.88	3.47	5.95	0.50	0.99	6.45	2.98	4.46
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	482.36	27.18	15.70	4.59	2.30	0.38	1.91	6.51	0.77	4.59
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	188.12	33.27	13.91	0.91	1.51	0.60	0.60	6.96	3.02	3.02
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	551.01	54.81	28.07	3.09	5.53	0.66	1.33	2.87	0.88	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	281.90	29.82	8.81	3.39	7.45	0.00	0.68	1.36	3.39	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	158.40	45.99	40.88	0.00	20.44	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	232.29	28.05	12.19	4.88	4.88	0.00	1.22	4.27	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	354.71	23.29	12.59	4.72	4.41	0.31	1.89	5.35	1.89	3.78
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	284.80	17.55	7.87	0.61	3.03	0.30	0.30	3.63	0.91	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	401.90	50.63	18.20	3.96	3.16	0.00	0.00	8.70	0.79	3.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	316.29	37.41	32.88	2.27	6.80	0.00	0.00	17.00	3.40	10.20
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	283.24	45.52	65.75	0.00	10.12	0.00	5.06	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	1019.29	326.97	416.04	14.41	10.81	2.98	3.11	5.34	5.84	2.86
Myoblast, donor2	11322-117D8	961.05	236.86	147.49	9.59	9.97	1.53	3.26	6.52	8.44	3.07
Myoblast, donor3	11398-118D3	1127.70	303.03	299.33	7.90	7.90	1.85	4.71	3.03	3.53	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	1.75	0.00	0.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	37.02	16.70	12.70	0.36	0.36	0.36	0.73	0.36	0.00	0.00
Neural stem cells, donor2	11352-117H2	25.03	5.78	13.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	47.79	6.83	17.07	0.00	1.14	1.14	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	7.71	19.37	15.19	0.44	0.44	0.22	0.00	0.22	0.00	0.00
Neurons, donor3	11655-122E8	55.91	14.80	13.98	1.64	0.82	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	173.47	153.88	47.14	3.68	4.39	0.59	0.59	0.24	0.83	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	80.75	147.82	24.09	1.63	1.95	0.98	0.33	1.63	0.98	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	205.77	123.34	47.13	3.41	5.62	0.00	0.60	1.40	1.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	542.35	158.16	64.97	7.71	7.30	1.38	2.06	5.92	2.75	3.30
Olfactory epithelial cells, donor2	11934-125I8	1103.97	218.57	125.49	7.82	9.41	1.01	4.49	8.68	9.12	5.65
Olfactory epithelial cells, donor3	11935-125I9	624.84	155.16	72.53	11.92	8.40	1.59	1.70	4.88	1.93	4.20
Olfactory epithelial cells, donor4	11936-126A1	1258.28	221.19	98.86	9.16	15.68	1.36	2.63	7.60	4.29	2.14
Oligodendrocyte - precursors, donor1	11496-119F2	349.06	140.83	68.61	18.05	17.45	4.21	19.86	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	300.11	182.49	119.11	5.32	4.89	1.28	0.64	0.64	0.43	0.64
Osteoblast - differentiated, donor2	11353-117H3	40.01	13.72	4.57	1.14	1.14	1.14	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	89.38	72.00	19.24	3.72	3.10	0.00	0.00	0.62	1.24	1.24
Osteoblast, donor1	11277-116H8	190.75	52.18	33.22	0.59	0.98	0.59	0.78	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	615.23	184.01	110.26	5.62	4.21	2.11	1.40	0.70	3.51	1.40
Osteoblast, donor3	11426-118G4	318.49	105.57	65.05	6.75	6.75	1.96	2.49	0.71	1.42	1.07
Pancreatic stromal cells, donor1	11249-116E7	1026.24	361.12	296.42	9.01	5.48	2.36	2.19	2.27	4.30	2.19
Pericytes, donor1	11491-119E6	103.37	32.16	12.68	0.78	0.00	0.11	0.00	0.11	0.11	0.11
Pericytes, donor2	11571-120E5	76.06	23.99	6.56	1.13	0.00	0.00	0.00	0.23	0.68	0.00
Pericytes, donor3	11652-122E5	284.02	124.92	80.57	2.44	2.03	1.22	1.22	0.41	1.22	0.81
Perineurial Cells, donor1	11499-119F5	414.90	380.43	212.14	5.88	2.26	1.24	0.90	1.47	1.24	0.23
Perineurial Cells, donor2	11579-120F4	48.95	43.52	21.99	0.55	1.10	0.37	0.46	0.09	0.09	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	0.32	0.00	0.00	0.32	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.49	0.00	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	154.50	104.99	87.30	16.98	2.15	2.87	0.96	0.24	1.20	0.00
Placental Epithelial Cells, donor2	11355-117H5	383.67	175.20	136.39	11.09	2.22	1.11	2.22	1.11	4.44	1.11
Placental Epithelial Cells, donor3	11427-118G5	161.77	118.19	56.15	5.10	0.79	0.79	1.96	0.98	0.59	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	140.82	77.21	45.57	6.65	6.96	1.90	0.95	6.33	3.80	4.43
Preadipocyte - breast, donor1	11467-119B9	278.94	82.16	58.15	12.57	7.32	2.44	1.50	0.38	0.75	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	116.43	72.70	44.77	6.40	6.66	1.96	1.17	0.00	0.52	0.13
Preadipocyte - breast, donor2	11328-117E5	112.35	51.11	27.02	4.73	6.53	0.68	0.00	1.35	1.13	0.68
Preadipocyte - omental, donor1	11468-119C1	230.17	63.40	37.40	9.16	10.55	2.98	0.85	0.85	0.96	0.32
Preadipocyte - omental, donor2	11329-117E6	130.07	70.71	41.03	10.48	8.29	2.62	2.18	0.87	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	131.50	32.95	17.62	5.73	7.16	2.86	0.86	0.57	1.00	0.86
Preadipocyte - perirenal, donor1	11469-119C2	80.71	26.58	16.73	4.92	5.91	1.97	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	354.41	53.44	44.53	3.07	1.84	0.92	1.54	0.31	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	1037.32	364.07	240.12	7.44	6.20	1.42	4.07	5.14	4.43	6.20
Preadipocyte - subcutaneous, donor3	11428-118G6	623.07	154.79	101.32	3.24	4.60	1.53	1.70	1.87	2.72	2.72
Preadipocyte - visceral, donor1	11280-116I2	1238.11	451.86	349.77	6.99	7.36	1.86	3.26	3.07	2.61	1.49
Preadipocyte - visceral, donor2	11357-117H7	533.35	119.19	59.36	7.36	3.68	1.38	1.84	2.30	1.84	2.76
Preadipocyte - visceral, donor3	11429-118G7	984.30	282.65	190.59	6.58	6.27	1.36	2.30	3.03	3.34	2.30
Prostate Epithelial Cells (polarized), donor1	11253-116F2	2.41	0.00	0.00	0.15	0.15	0.00	0.00	0.00	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	142.46	269.74	240.36	5.82	1.90	0.41	1.35	1.90	2.84	1.49
Prostate Epithelial Cells, donor3	11404-118D9	34.48	31.05	9.61	3.61	0.98	1.65	0.43	0.24	0.37	0.18
Prostate Stromal Cells, donor1	11254-116F3	254.23	79.50	59.34	3.53	3.64	1.48	1.59	1.14	1.14	0.34
Prostate Stromal Cells, donor2	11332-117E9	559.95	115.65	60.60	6.28	7.71	3.05	2.87	2.69	2.69	2.15
Prostate Stromal Cells, donor3	11405-118E1	193.54	45.88	19.50	2.40	4.28	0.94	0.73	1.04	1.04	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	31.39	18.61	6.20	0.73	0.36	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	25.92	26.06	8.66	3.47	0.83	2.08	0.42	0.07	0.21	0.07
Renal Epithelial Cells, donor1	11517-119H5	33.98	3.55	2.54	1.01	0.00	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	29.88	9.25	3.56	2.85	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	32.08	44.46	17.26	4.02	0.53	1.27	0.53	0.21	0.42	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	44.94	81.02	84.43	0.00	0.00	0.00	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	140.56	177.48	233.14	1.35	0.81	0.00	0.27	0.67	1.62	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	158.96	207.14	287.73	4.00	1.33	1.33	0.89	5.55	2.89	2.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	23.96	26.62	66.54	0.00	0.00	0.00	0.67	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	99.04	18.49	7.70	1.54	0.88	0.22	0.66	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	28.21	6.90	1.88	1.88	0.63	1.88	0.00	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	18.31	5.27	4.16	1.11	0.28	1.11	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	60.13	22.55	10.47	4.03	1.34	3.22	0.81	0.00	0.81	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	25.30	9.28	0.84	0.84	0.42	0.42	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	27.00	9.26	3.66	0.96	0.00	0.19	0.39	0.00	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	12.19	10.89	3.89	1.04	0.00	0.52	0.00	0.00	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.25	1.71	1.14	0.00	0.00	0.00	0.28	0.00	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	24.70	3.09	1.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	4.27	6.27	0.75	0.00	0.25	0.00	0.00	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	163.70	51.45	89.94	10.69	9.49	3.07	11.89	0.67	0.27	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	0.89	1.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	0.55	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.61	7.15	2.60	0.26	0.00	0.00	0.39	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	6.36	4.67	1.29	0.40	0.10	0.20	0.00	0.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	3.46	1.78	0.67	0.22	0.11	0.22	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.28	9.43	3.72	0.74	0.50	0.25	0.12	0.12	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	7.81	3.73	1.40	0.58	0.12	0.00	0.23	0.00	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	3.47	1.62	0.23	0.00	0.23	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.50	6.16	1.23	0.41	0.14	0.00	0.00	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	6.50	3.78	0.76	0.76	0.15	0.45	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	2.87	1.61	0.18	0.18	0.00	0.00	0.18	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	10.76	5.45	2.15	0.14	0.14	0.14	0.14	0.00	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	6.33	6.01	1.40	0.32	0.11	0.32	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	3.32	1.55	0.44	0.00	0.00	0.00	0.00	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.15	6.88	1.34	0.00	0.19	0.19	0.00	0.19	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	8.66	6.06	1.68	0.37	0.09	0.00	0.00	0.09	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	4.51	1.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	15.39	5.18	1.99	0.53	0.00	0.27	0.00	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	7.40	4.09	1.17	0.39	0.19	0.10	0.19	0.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	2.67	0.38	0.38	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	11.11	6.41	1.50	0.85	0.43	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	8.41	3.08	1.40	0.56	0.00	0.28	0.28	0.00	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	3.08	0.51	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	11.12	6.02	2.01	0.36	0.00	0.00	0.00	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	7.85	5.27	2.33	0.49	0.25	0.25	0.00	0.12	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	2.96	1.34	0.13	0.27	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	13.92	9.67	3.07	0.71	0.24	0.47	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	7.34	5.56	1.79	0.79	0.00	0.60	0.20	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	2.10	1.64	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	12.23	7.88	2.28	0.00	0.62	0.21	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	8.63	6.19	1.99	0.22	0.00	0.00	0.00	0.00	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	2.30	0.84	0.42	0.21	0.00	0.42	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	12.25	6.46	2.15	1.62	0.13	0.00	0.13	0.13	0.13	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	9.03	4.77	1.36	0.17	0.17	0.17	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	1.35	1.16	0.19	0.00	0.19	0.00	0.00	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	13.58	9.11	3.27	1.20	0.17	0.69	0.17	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	7.54	2.74	1.10	0.55	0.14	0.14	0.27	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	3.61	2.30	0.66	0.00	0.16	0.16	0.33	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.98	3.58	0.85	0.51	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	7.55	3.40	1.18	0.15	0.00	0.15	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	2.40	0.53	0.27	0.27	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	0.97	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	0.24	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	1.61	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	0.66	0.28	0.00	0.00	0.00	0.09	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	0.35	0.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	0.49	0.37	0.00	0.00	0.00	0.00	0.00	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	0.29	0.29	0.15	0.00	0.15	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	1.21	0.30	0.30	0.00	0.00	0.00	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	0.60	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	0.43	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	0.60	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	89.52	48.15	24.64	0.94	0.00	0.19	0.56	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	258.58	272.19	105.47	0.00	0.00	0.00	0.00	0.00	0.00	10.21
Schwann Cells, donor3	11659-122F3	131.67	131.89	56.96	3.07	1.53	0.00	1.31	3.29	0.88	0.88
Sebocyte, donor1	11220-116B5	150.09	282.65	285.94	2.74	0.55	1.64	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	109.83	266.08	171.87	1.84	0.00	0.92	2.30	0.00	1.38	0.46
Sebocyte, donor3	11378-118B1	149.23	105.32	38.34	1.86	0.62	0.41	0.21	0.00	1.03	0.21
Sertoli Cells, donor1	11255-116F4	235.24	139.15	87.80	16.57	13.25	0.00	1.66	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	432.13	124.27	56.49	5.65	28.24	2.82	0.00	5.65	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	325.61	88.33	45.22	1.85	2.02	0.35	0.79	0.97	0.79	0.26
Skeletal Muscle Cells, donor2	11358-117H8	5.78	4.34	0.72	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	368.69	102.83	65.21	1.67	0.00	0.00	1.67	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	792.54	380.01	217.42	2.20	3.14	0.16	2.04	4.24	3.30	1.89
Skeletal Muscle Cells, donor5	11455-119A6	530.36	342.33	174.95	1.93	3.86	0.89	1.49	4.61	2.38	1.64
Skeletal Muscle Cells, donor6	11459-119B1	788.29	439.70	247.17	2.77	2.92	0.92	2.46	3.54	2.77	2.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	314.26	670.10	272.80	2.27	3.28	1.13	1.26	1.51	2.39	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	258.12	462.45	165.95	2.28	3.00	0.14	1.43	2.85	1.57	1.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	679.69	430.67	239.10	2.38	3.17	0.50	1.39	6.05	3.37	3.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	169.43	36.65	20.39	1.10	1.77	0.59	0.34	0.17	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	203.38	70.21	28.95	2.90	0.00	0.72	0.72	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	196.63	37.84	17.06	0.69	1.51	0.55	1.38	0.00	0.69	0.14
Skin - palm, donor1	10286-104F7	163.85	75.21	64.47	13.43	5.37	0.00	0.00	8.06	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	49.73	128.73	57.95	3.17	1.30	0.72	0.58	2.45	1.44	2.02
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	49.07	94.06	53.16	0.82	0.82	0.82	0.82	2.45	1.64	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	59.46	160.08	86.08	2.86	1.82	1.04	1.04	2.73	1.69	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	47.26	119.13	95.08	4.31	0.70	2.36	1.67	0.56	0.56	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	71.88	75.95	56.12	3.52	1.13	1.27	1.41	1.13	0.42	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	65.76	133.21	88.17	2.33	0.63	1.69	1.06	0.42	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	21.14	23.46	11.54	3.60	0.60	2.10	0.45	0.37	0.30	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	326.79	82.39	34.25	4.32	10.49	0.62	0.93	1.85	1.54	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	247.01	116.50	76.48	4.00	8.89	1.56	3.33	1.33	0.67	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	107.57	35.27	23.51	2.94	3.53	2.35	0.59	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	91.49	51.71	39.56	3.54	1.77	1.77	0.66	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	159.09	24.02	31.50	2.36	1.97	1.18	0.00	0.79	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	127.47	40.17	25.49	3.86	10.82	1.55	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	22.02	23.02	7.01	2.00	0.00	0.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	99.14	43.65	49.37	3.19	2.40	0.67	0.67	0.13	0.40	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	795.96	303.00	201.93	4.88	6.43	0.89	1.55	5.76	2.88	5.32
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	81.56	44.68	35.98	6.27	4.99	1.15	2.18	1.02	0.26	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	132.19	165.73	112.00	2.60	0.00	1.30	0.33	0.65	0.00	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	268.75	125.81	73.54	5.02	1.48	0.59	0.30	1.18	0.89	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	79.87	44.13	24.06	1.71	2.28	0.43	0.57	0.57	0.57	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	315.91	47.01	27.65	2.11	1.46	0.98	0.65	0.16	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	382.98	202.75	63.02	5.18	7.31	1.52	1.52	7.31	2.44	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	339.45	86.38	58.85	3.28	2.27	0.76	1.26	0.00	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	12.24	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	87.74	40.05	27.66	2.86	2.38	0.48	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	173.58	106.48	57.51	1.77	2.80	0.59	1.03	0.88	0.44	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	98.58	85.45	29.49	1.51	1.72	0.22	0.22	0.43	0.86	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	129.94	89.84	43.24	0.94	0.84	0.63	1.15	0.84	0.94	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	151.74	31.86	28.77	2.47	0.62	0.77	0.31	0.31	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	95.93	31.26	30.18	3.23	4.31	0.00	3.23	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	45.72	12.85	5.98	2.39	0.60	1.49	0.30	0.60	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	222.25	43.02	26.29	1.71	0.68	0.00	0.00	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	83.87	203.55	53.24	1.18	2.12	0.39	0.71	0.79	0.71	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	579.09	172.90	137.58	12.48	15.60	3.12	4.03	1.71	2.42	1.51
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	147.23	74.64	59.62	3.41	5.23	2.05	0.91	0.91	0.23	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	68.23	36.23	23.55	3.62	3.02	0.00	0.60	0.60	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	397.12	189.69	129.02	2.65	2.91	0.00	1.32	2.38	1.59	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	486.16	109.46	82.56	6.66	1.86	1.86	0.93	1.60	1.20	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	155.77	40.32	19.03	2.25	2.25	0.25	0.25	0.38	0.88	1.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	458.11	83.20	39.06	3.80	3.04	1.01	0.76	1.78	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	449.00	197.51	183.94	2.41	7.54	0.90	1.66	1.81	0.75	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	227.30	93.77	42.76	2.25	3.75	1.50	0.00	3.00	2.25	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	113.71	233.89	251.98	1.29	0.00	0.00	0.00	1.29	0.00	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	240.91	40.93	25.58	1.86	4.65	1.40	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	101.48	33.83	22.21	4.04	1.51	1.51	0.50	0.00	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	126.30	53.28	43.25	5.64	6.89	1.25	0.94	1.25	1.88	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	215.35	68.14	40.41	2.06	0.88	0.59	0.29	1.47	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	854.23	550.66	430.53	7.75	5.75	1.00	2.92	1.67	1.83	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	142.95	195.27	56.53	2.80	5.14	0.93	0.47	2.34	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	82.47	29.79	28.93	4.17	1.30	1.15	0.72	0.29	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	129.01	59.66	54.31	3.57	2.29	1.53	1.78	1.02	0.76	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	134.63	33.47	25.76	1.88	1.32	0.19	1.13	0.19	0.19	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	220.94	199.28	107.32	1.12	2.10	1.12	1.26	0.42	0.56	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	143.86	127.61	75.41	2.26	3.10	0.50	0.75	0.25	0.34	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	21.43	10.48	1.43	0.48	0.00	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	68.26	24.47	26.91	2.45	1.47	0.00	0.98	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	923.34	100.53	86.39	5.97	6.41	1.99	1.77	2.21	1.77	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	391.47	131.95	69.34	2.05	2.93	0.29	0.88	1.76	0.88	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	117.01	16.91	2.14	0.39	2.72	0.00	0.39	0.39	0.39	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	454.33	75.10	42.84	4.76	6.61	1.06	0.79	3.97	3.97	4.23
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	581.35	116.79	63.23	2.60	4.09	1.86	0.74	3.72	2.23	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	915.59	162.78	148.05	8.26	6.83	2.16	2.87	6.83	5.39	4.31
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	588.81	65.01	60.75	5.68	7.95	1.70	1.70	5.11	3.12	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	691.63	270.98	152.82	4.73	8.27	0.39	6.70	5.91	3.54	3.54
Smooth muscle cells - airway, control, donor1	11966-126D4	524.92	88.63	51.04	2.03	6.86	1.27	0.76	5.59	4.32	2.79
Smooth muscle cells - airway, control, donor2	11967-126D5	467.60	45.92	12.78	1.60	4.39	1.20	0.40	3.19	1.20	2.40
Smooth muscle cells - airway, control, donor3	11968-126D6	245.37	33.44	9.20	2.93	2.51	0.00	0.00	3.34	2.09	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	178.76	28.42	11.00	2.29	3.67	1.38	0.00	1.38	0.92	0.46
Synoviocyte, donor1	11291-117A4	1155.35	244.74	180.10	14.64	11.28	4.04	3.70	3.53	4.21	3.20
Synoviocyte, donor2	11368-117I9	196.79	63.36	27.66	6.37	7.54	2.01	0.34	2.01	2.85	2.51
Synoviocyte, donor3	11440-118H9	334.44	75.96	24.58	4.69	9.16	1.56	0.67	0.89	0.45	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	311.59	65.75	41.81	1.07	0.71	0.00	0.36	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	109.01	23.78	23.78	0.00	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	67.61	29.17	13.89	0.23	0.23	0.23	0.23	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	53.48	109.68	77.71	2.51	0.86	1.43	0.86	0.22	0.57	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	79.25	109.40	78.09	0.39	0.00	0.39	0.39	0.00	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	36.65	61.85	44.09	2.29	1.15	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	159.56	57.21	96.20	10.58	11.07	1.85	12.06	0.37	0.86	0.49
Urethra, donor2	10319-105A4	152.87	50.36	41.36	3.60	1.80	1.80	0.00	5.40	1.80	7.19
Urothelial Cells, donor1	11520-119H8	125.92	104.94	75.45	1.86	0.00	1.33	0.27	0.27	1.06	0.00
Urothelial Cells, donor2	11600-120H7	63.29	75.31	34.85	1.60	0.00	1.20	0.40	0.00	1.20	0.40
Urothelial Cells, donor3	11681-122H7	91.22	78.62	32.55	1.15	0.46	0.69	0.00	1.38	0.46	0.23
Urothelial cells, donor0	11216-116B1	72.89	254.55	123.48	5.80	0.00	3.57	0.67	0.45	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	0.00	0.00	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.34	0.34	0.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	1.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	425.94	412.74	696.11	25.52	3.52	0.00	2.64	31.68	8.80	19.36
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	476.24	361.16	301.38	8.10	2.23	1.68	1.40	6.98	2.51	7.26
achilles tendon, donor2	10292-104G4	90.93	45.46	101.26	4.13	0.00	0.00	0.00	8.27	2.07	8.27
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	46.66	0.51	0.00	3.06	0.25	3.82	1.27	0.25	0.25	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	0.29	0.00	0.00	0.00	0.00	0.29	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	21.49	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	7.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	11.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	11.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2.45	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	6.67	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	0.47	0.24	0.00	2.12	0.00	0.71	0.00	0.00	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	372.44	249.12	282.16	7.45	10.08	3.57	0.47	1.09	1.09	0.31
adipose, donor1	10184-103D4	2.35	1.76	1.17	0.00	0.00	0.00	0.00	0.00	0.00	0.59
adipose, donor2	10185-103D5	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	11.98	1.09	0.27	0.27	0.00	0.00	0.00	0.27	0.00	0.27
adipose, donor4	10187-103D7	12.13	70.21	19.94	0.00	0.00	0.00	0.87	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	0.00	0.00	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	40.96	4.14	1.07	1.60	0.00	3.34	0.00	0.00	0.13	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	82.89	20.72	11.79	1.07	0.36	0.00	0.00	1.07	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	823.30	144.91	70.71	28.29	4.17	5.10	3.01	1.85	1.85	0.93
amniotic membrane cells, donor2	12236-129G4	681.62	277.24	136.59	28.06	2.37	3.38	4.06	2.70	2.03	0.68
amniotic membrane cells, donor3	12237-129G5	720.89	261.02	94.27	39.48	7.95	4.12	3.54	10.61	3.24	4.71
amygdala - adult, donor10196	10167-103B5	1.19	1.19	0.00	1.19	0.00	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	6.49	4.46	4.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	17.75	4.84	5.49	0.97	0.32	0.32	0.00	0.65	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	53.99	103.39	53.99	3.95	0.89	1.02	0.00	0.25	0.38	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	172.99	84.73	39.23	10.40	7.45	1.96	0.59	2.35	0.78	1.77
appendix, adult	10189-103D9	146.32	43.47	53.95	4.27	1.55	1.16	0.00	0.39	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	0.00	0.00	0.34	0.00	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	77.45	36.68	66.58	4.08	1.36	0.00	0.00	0.00	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	37.23	31.29	20.72	2.32	0.43	0.58	0.14	0.14	0.14	0.00
b cell line:RPMI1788	10427-106D4	8.18	0.00	0.00	0.89	0.00	3.87	0.15	0.00	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	1513.20	525.76	511.89	12.76	14.98	3.88	3.33	6.10	9.99	3.33
bile duct carcinoma cell line:HuCCT1	10432-106D9	478.79	405.36	583.28	7.74	1.69	1.29	1.69	1.49	1.29	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	26.95	5.69	2.34	4.35	0.17	1.34	0.00	0.17	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	227.60	180.56	139.06	4.89	3.59	1.85	0.76	0.98	1.09	0.11
blood, adult, pool1	10053-101G8	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	1220.29	254.34	256.05	4.28	2.57	0.00	0.86	5.14	1.71	1.71
bone marrow, adult	10192-103E3	105.27	31.04	58.04	0.67	1.35	0.00	0.67	3.37	0.00	0.67
brain, adult, donor1	10084-102B3	9.23	5.13	2.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	6.01	3.12	6.12	0.56	0.11	0.11	0.11	0.00	0.00	0.00
brain, fetal, pool1	10085-102B4	18.70	0.00	2.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	14.54	2.64	1.32	0.33	0.33	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	208.35	75.13	71.34	13.26	3.16	2.53	0.00	1.89	0.63	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	180.14	84.61	51.45	3.05	1.52	0.64	1.02	0.64	0.76	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	689.56	99.88	63.39	14.84	2.78	3.71	4.02	4.64	0.93	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	331.98	90.02	49.73	9.44	1.84	2.07	4.83	2.99	2.53	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	93.69	3.39	0.73	2.91	0.24	0.97	0.00	0.48	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	2.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	2.73	0.22	0.11	0.22	0.22	0.11	0.00	0.11	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	463.30	506.08	195.21	0.63	2.22	0.63	3.17	5.07	5.39	6.65
carcinosarcoma cell line:JHUCS-1	10642-109A3	20.50	12.24	5.86	0.80	0.53	0.00	0.00	0.27	0.00	0.53
caudate nucleus - adult, donor10196	10177-103C6	16.12	2.30	0.00	0.00	0.00	0.00	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	5.19	2.01	4.69	0.00	0.17	0.00	0.00	0.17	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	4.58	3.06	1.53	0.00	0.00	0.76	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	17.21	5.13	11.72	0.37	0.37	0.00	0.37	0.73	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	2.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	5.98	2.78	2.56	0.21	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	2.07	1.72	0.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	7.47	4.98	4.98	0.00	0.83	0.00	0.00	1.66	0.00	0.83
cerebral meninges, adult	10188-103D8	32.78	11.60	8.57	1.51	0.76	0.00	0.00	0.00	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	16.81	3.65	8.77	0.73	0.00	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	8.77	13.80	3.74	2.73	0.58	1.01	0.58	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	236.81	105.06	82.86	6.46	2.15	0.99	0.99	0.66	0.83	0.33
cervix, adult, pool1	10013-101C4	349.41	143.00	133.76	4.20	3.25	1.05	0.31	0.84	1.15	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	8.50	8.22	6.13	0.00	0.28	0.00	0.14	0.42	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	680.56	41.80	30.04	3.92	0.00	1.31	1.31	2.61	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	89.98	2.11	1.37	0.12	0.12	0.12	0.00	0.12	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	5.42	0.00	0.00	0.12	0.00	0.00	0.00	0.00	0.12	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	232.91	0.71	0.24	0.24	0.24	0.00	0.00	0.00	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	599.47	74.65	70.38	13.96	1.99	1.14	0.57	2.28	1.99	0.85
chorionic membrane cells, donor2	12239-129G7	390.37	108.08	80.04	11.83	2.09	2.59	1.29	0.60	1.19	0.20
chorionic membrane cells, donor3	12240-129G8	513.22	69.78	86.82	9.89	1.10	1.10	1.10	5.49	2.75	3.30
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	0.00	0.00	0.00	0.00	0.00	0.24	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	0.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	572.60	126.18	61.72	40.23	5.94	15.31	12.80	11.43	4.57	6.17
clear cell carcinoma cell line:TEN	10636-108I6	86.06	98.20	57.95	9.72	0.52	2.26	0.87	0.00	0.52	0.35
colon carcinoma cell line:CACO-2	10513-107D9	7.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	4.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	98.77	52.36	60.69	1.19	1.19	2.38	0.00	1.19	0.00	7.14
colon, adult, pool1	10014-101C5	119.27	70.50	69.33	3.53	1.18	0.82	0.24	0.47	0.59	0.59
colon, fetal, donor1	10070-101I7	190.34	109.38	55.00	1.24	3.09	0.00	0.62	6.18	1.24	7.42
common myeloid progenitor CMP, donor1	12130-128D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	90.94	0.00	0.00	11.47	0.00	23.80	2.12	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	122.25	0.00	0.00	9.96	0.45	17.66	1.51	0.60	0.15	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	111.82	0.00	0.00	11.70	0.28	19.32	0.56	0.42	0.42	0.00
corpus callosum, adult, pool1	10042-101F6	10.17	8.62	6.97	0.33	0.11	0.00	0.00	0.00	0.00	0.00
cruciate ligament, donor2	10295-104G7	391.46	62.41	94.83	6.48	2.43	0.00	0.81	2.43	0.00	4.86
diaphragm, fetal, donor1	10069-101I6	166.13	81.06	162.92	1.61	4.01	0.00	0.80	7.22	1.61	3.21
diencephalon, adult	10193-103E4	3.36	1.68	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	2.53	0.23	0.00	0.00	0.00	0.46	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	233.36	116.42	119.24	11.80	2.82	3.08	1.80	1.28	0.26	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	23.59	13.72	8.43	1.20	1.20	0.00	0.48	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	92.19	83.22	61.30	2.99	1.99	1.00	0.50	5.98	1.99	2.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	54.73	54.73	37.45	1.44	0.00	0.00	0.00	1.44	1.44	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	89.01	64.00	65.47	2.94	0.74	0.00	0.74	1.47	1.47	0.74
dura mater, adult, donor1	10041-101F5	62.35	19.33	27.67	0.25	1.07	0.41	0.00	0.08	0.25	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	32.42	1.33	2.89	2.22	0.00	1.55	0.67	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	47.14	16.62	5.16	0.29	0.72	0.14	0.43	0.14	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	274.39	31.45	19.12	4.32	0.00	2.47	0.00	3.08	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	186.17	34.51	25.12	6.05	0.30	2.12	0.00	2.42	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	307.51	39.21	41.37	6.17	0.00	1.23	0.93	0.62	0.31	0.93
embryonic pancreas cell line:2C6	10603-108E9	221.98	31.52	21.02	3.94	0.00	2.63	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	119.33	74.08	52.63	9.39	1.34	0.67	2.35	1.01	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	361.02	19.94	13.23	0.54	0.72	0.00	0.36	1.27	1.09	2.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	4.34	1.45	1.29	0.64	0.16	0.16	0.00	0.00	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	754.88	483.43	440.63	5.89	1.45	2.11	1.89	2.11	1.78	1.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	372.41	613.50	701.71	7.81	3.30	3.63	3.08	1.76	2.42	0.77
epididymis, adult	10197-103E8	125.80	79.12	95.66	1.67	1.26	0.21	0.00	1.26	0.84	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	802.60	683.38	750.44	6.21	4.97	0.53	3.73	13.13	6.21	16.68
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	187.58	72.36	101.06	3.15	1.97	1.18	2.36	0.79	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	0.39	0.92	0.79	1.05	0.26	0.39	0.26	0.00	0.00	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.20	1.48	0.69	0.59	0.49	0.20	0.30	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.67	2.24	1.01	1.68	0.22	0.22	0.00	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	95.77	104.37	115.31	5.31	2.65	2.76	0.21	0.11	0.64	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3.38	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	86.92	50.71	101.41	0.00	2.41	0.00	0.00	2.41	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	73.65	23.15	56.81	0.00	0.00	0.00	0.00	2.10	0.00	2.10
eye - muscle medial, donor2	10299-104H2	71.43	16.37	37.21	1.49	0.00	0.00	0.00	5.95	0.00	1.49
eye - muscle superior, donor2	10297-104G9	100.89	34.39	61.91	1.15	2.29	0.00	0.00	4.59	0.00	3.44
eye - vitreous humor, donor1	10268-104D7	17.49	0.00	4.37	0.00	0.00	0.00	1.46	0.00	0.00	2.91
eye, fetal, donor1	10054-101G9	62.54	43.47	41.19	2.03	2.54	0.51	0.25	0.51	0.51	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	197.98	92.71	62.57	2.56	0.90	0.51	0.64	2.31	1.28	2.82
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	98.05	23.03	9.26	2.61	0.95	0.47	0.47	1.19	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	9.85	3.57	5.63	0.09	0.19	0.00	0.00	0.00	0.09	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	10.21	1.80	0.60	0.30	0.30	0.30	0.30	0.00	0.00	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	63.27	170.99	125.82	3.11	0.73	2.83	0.27	0.18	0.37	0.37
gall bladder, adult	10198-103E9	167.80	63.98	57.22	3.62	0.97	0.72	0.00	0.97	0.24	0.72
gamma delta positive T cells, donor1	11937-126A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	87.02	90.61	65.27	4.44	1.27	1.27	1.06	1.27	1.06	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	52.61	3.48	0.39	2.71	0.39	1.35	0.00	0.58	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	5.90	0.82	0.49	0.33	0.00	0.00	0.00	0.16	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	1.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.13	0.00	0.23	0.46	0.00	0.23	0.00	0.00	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	7.23	3.79	1.49	2.64	0.00	1.15	0.11	0.00	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	6.44	2.94	1.26	0.42	0.00	0.14	0.00	0.00	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	43.40	6.98	5.49	2.74	0.75	0.25	0.00	0.25	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	245.30	53.09	36.52	3.80	2.64	0.74	1.06	0.63	0.21	1.06
glioblastoma cell line:A172, tech_rep2	10444-106F3	303.77	49.72	30.33	3.23	1.83	0.84	0.56	2.53	0.70	0.70
glioblastoma cell line:T98G	10485-107A8	303.64	104.52	70.20	2.43	0.66	1.55	0.99	0.44	1.32	0.22
glioma cell line:GI-1	10413-106B8	181.88	163.13	88.16	1.17	1.46	0.88	0.59	0.59	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	8.75	4.37	6.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	47.60	12.45	9.28	0.49	0.24	0.00	0.00	0.24	0.00	0.49
globus pallidus, adult, donor10258	10367-105F7	17.80	10.95	5.48	2.74	0.00	0.00	0.00	0.00	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	17.59	7.99	17.59	0.00	0.53	0.00	0.00	1.07	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	138.88	42.24	21.44	1.60	7.04	0.32	1.28	0.96	0.32	0.64
hIPS +CCl2, biol_rep1	14383-156B9	14.23	4.13	0.92	1.38	0.46	0.46	0.46	0.00	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	14.18	4.12	1.83	0.91	0.00	0.91	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	9.02	3.22	0.00	1.93	0.00	0.00	0.64	0.00	0.64	0.64
hIPS, biol_rep1	14380-156B6	37.37	7.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	17.83	2.06	0.69	2.06	0.00	0.69	0.00	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	9.93	0.00	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	67.53	0.86	0.00	1.72	0.57	1.72	0.86	0.57	0.29	0.57
heart - mitral valve, adult	10205-103F7	160.84	79.53	141.41	14.35	5.98	2.39	1.20	2.09	1.79	0.90
heart - pulmonic valve, adult	10206-103F8	187.22	91.52	129.43	18.56	9.41	6.01	0.26	6.54	1.31	4.97
heart - tricuspid valve, adult	10207-103F9	67.44	39.13	136.55	11.66	5.83	0.00	0.00	5.00	0.83	9.16
heart, adult, diseased post-infarction, donor1	10050-101G5	85.70	26.12	42.44	9.18	3.47	2.04	0.41	0.00	0.00	0.41
heart, adult, diseased, donor1	10051-101G6	129.03	50.25	91.13	15.76	5.54	4.26	0.43	0.43	1.28	0.85
heart, adult, pool1	10016-101C7	138.22	39.10	102.11	32.89	7.36	10.35	1.38	0.23	0.46	0.00
heart, fetal, pool1	10046-101G1	225.90	185.54	372.42	17.97	4.42	4.72	0.62	0.82	0.62	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	307.91	36.71	18.51	8.33	8.02	2.47	1.23	1.54	0.62	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	12.34	4.56	3.89	1.33	0.11	0.78	0.11	0.00	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	18.39	0.00	0.00	0.00	0.00	0.10	0.00	0.00	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	3.79	0.95	3.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	12.04	4.49	5.10	0.00	0.61	0.00	0.00	0.41	0.20	0.41
hippocampus, adult, donor10258	10374-105G5	7.97	1.49	2.49	0.00	0.00	0.50	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	12.69	3.52	6.34	0.70	0.00	0.00	0.00	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	23.19	6.71	3.66	0.00	0.00	0.00	1.22	0.00	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.29	3.34	2.55	0.98	0.00	0.20	0.39	0.00	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	20.82	7.62	3.81	0.76	0.00	0.25	0.51	0.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	2.82	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	4.65	0.00	0.26	0.00	0.00	0.00	0.00	0.00	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	2.28	0.38	0.38	0.00	0.00	0.38	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	3.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	2.15	0.00	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.65	2.13	2.84	0.47	0.00	0.00	0.00	0.00	0.24	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	16.23	1.61	2.73	0.16	0.16	0.00	0.00	0.16	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	15.49	4.71	4.71	0.00	0.00	0.67	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	16.90	4.07	2.97	0.78	0.16	0.00	0.31	0.00	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	26.04	2.95	3.44	0.49	0.49	0.49	1.47	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	19.20	4.36	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	3.82	0.19	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	6.54	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	9.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	2.45	0.00	0.00	0.00	0.00	0.19	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1.25	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	17.80	1.80	0.82	0.33	0.00	0.16	0.00	0.16	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.58	2.90	1.74	0.29	0.00	0.00	0.58	0.58	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	19.43	0.60	1.49	0.00	0.30	0.30	0.00	0.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	24.39	2.40	1.11	1.11	0.18	0.37	0.55	0.37	0.18	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	28.53	5.71	2.85	2.28	0.29	0.86	1.14	0.00	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	24.91	4.08	2.45	0.41	0.00	0.41	0.41	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	16.20	4.22	2.46	0.00	0.00	0.00	0.00	0.00	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	8.24	2.85	2.53	0.00	0.00	0.00	0.32	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	9.68	1.82	1.51	0.00	0.00	0.30	0.00	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	3.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	5.98	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	1.54	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	34.26	6.65	2.81	0.26	0.51	0.00	0.26	0.26	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	9.09	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	49.06	5.04	4.03	1.01	0.34	0.00	0.34	0.34	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	14.73	2.17	1.69	0.24	0.00	0.24	0.00	0.00	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	15.60	4.46	2.23	1.34	0.00	0.45	1.34	0.45	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	17.56	4.88	0.98	2.44	0.00	0.00	0.98	1.46	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1.53	0.61	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2.32	0.99	0.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	2.74	0.00	0.00	0.00	0.00	0.00	0.00	0.55	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	2.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	1.78	0.00	0.00	0.00	0.00	0.36	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	31.03	2.39	1.19	0.00	0.00	0.00	0.00	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	36.56	8.94	7.18	0.41	0.14	0.14	0.68	0.27	0.41	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	32.87	5.39	4.58	0.54	0.27	0.00	0.54	0.27	0.00	0.27
immature langerhans cells, donor1	11904-125F5	3.39	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	7.13	1.58	0.00	1.58	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	6.91	4.54	6.34	0.28	0.09	0.09	0.00	0.00	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	38.04	70.88	31.86	1.63	0.00	0.65	0.33	0.65	1.30	0.00
kidney, adult, pool1	10017-101C8	14.02	10.31	15.52	0.90	0.40	0.20	0.10	0.00	0.00	0.00
kidney, fetal, pool1	10045-101F9	18.04	9.34	16.27	0.99	0.57	0.14	0.07	0.00	0.07	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	97.57	115.46	94.02	17.89	2.27	1.42	4.12	0.14	0.71	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	46.59	9.82	6.22	2.21	1.38	1.24	0.55	0.28	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	83.86	52.48	42.39	6.24	0.92	1.10	0.73	0.55	0.55	0.73
left atrium, adult, donor1	10079-102A7	274.06	43.59	68.11	8.17	9.81	1.63	2.72	3.27	1.09	3.27
left ventricle, adult, donor1	10078-102A6	84.44	58.15	94.56	20.23	7.08	3.03	1.52	1.52	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	1.64	1.64	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	343.80	118.55	83.35	5.03	7.90	0.72	1.44	2.16	1.44	1.08
leiomyoma cell line:15242A	10570-108B3	257.07	108.15	80.98	2.17	3.80	1.09	1.09	5.43	3.26	3.80
leiomyoma cell line:15425	10571-108B4	506.27	137.43	104.65	7.53	4.86	1.21	2.91	2.43	2.91	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	228.58	44.45	57.14	19.05	19.05	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	39.73	9.41	6.27	1.05	0.00	0.00	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.83	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	275.55	122.78	69.51	4.84	1.09	0.47	1.56	2.03	1.87	1.56
liposarcoma cell line:SW 872	10726-110A6	217.60	98.32	69.57	3.78	1.58	0.61	0.49	2.19	0.61	1.22
liver, adult, pool1	10018-101C9	8.75	6.00	7.78	0.49	0.16	0.00	0.00	0.00	0.00	0.00
liver, fetal, pool1	10086-102B5	6.58	5.64	4.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	10.94	2.33	3.50	0.15	0.15	0.00	0.00	0.29	0.15	0.44
locus coeruleus, adult, donor10252	10165-103B3	16.43	2.58	5.91	0.37	0.00	0.00	0.18	0.18	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	6.77	2.54	2.26	0.00	0.00	0.00	0.00	0.00	0.00	0.56
locus coeruleus, newborn, donor10223	10362-105F2	31.13	11.36	28.18	0.42	0.84	0.84	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	76.12	13.70	5.40	6.78	0.97	1.25	0.97	0.28	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	419.85	107.55	62.74	15.86	3.45	2.76	4.14	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	109.80	46.66	27.95	5.54	2.64	2.11	5.27	0.53	0.66	0.40
lung, adult, pool1	10019-101D1	762.98	67.10	142.82	23.39	36.03	5.08	47.96	1.30	1.89	0.47
lung, fetal, donor1	10068-101I5	1862.28	365.89	710.38	41.10	43.38	6.56	85.34	2.85	4.28	1.71
lung, right lower lobe, adult, donor1	10075-102A3	845.41	49.49	93.93	30.24	40.78	2.29	57.28	9.62	5.96	11.00
lymph node, adult, donor1	10077-102A5	28.88	8.05	8.99	0.47	0.00	0.00	0.47	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	207.78	3.73	1.75	7.67	0.44	4.38	0.88	0.44	0.88	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.30	0.00	0.00	0.15	0.00	0.15	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	678.75	164.80	136.77	6.80	1.70	0.85	3.40	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	1675.17	396.04	287.71	7.99	21.31	1.33	2.66	3.55	4.88	2.22
mature adipocyte, donor2	12232-129F9	1415.76	322.29	306.10	11.21	18.89	3.32	2.28	3.74	2.49	0.62
mature adipocyte, donor3	12233-129G1	1518.15	394.71	307.71	13.51	28.45	5.93	3.08	1.19	1.19	0.24
mature adipocyte, donor4	12234-129G2	1392.42	386.40	256.11	12.11	23.95	3.16	2.37	2.37	2.37	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	2.26	0.00	2.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	18.39	5.70	5.52	0.18	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	0.95	0.64	2.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	11.09	5.97	10.66	0.00	0.00	0.00	0.43	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	4.05	1.52	3.88	0.00	0.00	0.17	0.00	0.00	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	21.86	3.18	6.15	0.42	0.21	0.00	0.00	0.42	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	0.00	1.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	15.79	4.67	8.26	0.72	0.72	0.00	1.08	0.72	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	6.49	3.24	1.95	1.30	0.65	0.65	0.00	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	18.27	5.11	3.56	0.15	0.15	0.31	0.00	0.15	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	20.24	9.22	13.39	0.82	0.49	0.33	0.16	0.00	0.00	0.00
medulla oblongata, newborn, donor10223	10361-105F1	14.58	5.21	5.55	0.35	0.00	0.00	0.00	0.69	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	17.05	0.66	0.00	0.00	0.00	0.00	0.00	0.22	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	144.65	174.73	130.34	3.18	1.10	0.61	0.86	3.42	0.49	1.59
melanoma cell line:COLO 679	10514-107E1	18.83	0.29	0.29	0.00	0.00	0.00	0.14	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	70.85	5.16	1.90	0.27	0.27	0.27	0.27	0.27	0.81	0.81
meningioma cell line:HKBMM	10691-109F7	54.99	15.20	9.23	4.16	0.18	1.63	0.36	0.18	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	827.78	447.72	343.08	3.84	6.60	1.38	1.38	2.30	3.53	1.84
mesenchymal precursor cell - adipose, donor2	11748-123G2	188.32	102.52	72.89	0.73	0.55	0.00	0.91	1.09	0.55	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	935.87	489.47	345.78	4.56	5.80	0.41	1.66	2.90	4.14	2.07
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	369.17	123.48	67.01	3.93	8.43	1.69	1.26	1.55	1.12	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	336.61	75.68	34.08	2.70	5.58	1.35	0.58	1.54	0.77	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	969.63	203.36	131.18	10.41	13.19	3.47	1.39	2.08	2.08	4.16
mesenchymal precursor cell - cardiac, donor1	11752-123G6	57.15	32.78	15.45	2.75	5.15	0.51	0.51	0.17	0.17	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	360.00	166.54	87.53	4.60	8.63	1.15	1.61	2.30	1.61	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	220.31	70.17	37.93	2.39	3.05	0.93	0.66	0.40	0.93	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	52.40	26.47	14.85	1.62	1.62	1.08	0.54	0.14	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	265.46	88.35	63.45	3.27	3.41	2.56	0.85	0.71	0.43	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	108.03	50.06	34.58	5.93	2.31	1.65	0.99	0.00	0.66	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	208.25	61.85	44.42	3.32	3.87	1.25	1.11	0.97	0.55	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	746.69	154.29	89.02	3.84	5.24	0.70	0.70	3.49	2.79	3.49
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	313.80	66.97	41.45	2.25	5.31	2.25	0.41	1.43	0.82	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	379.22	102.44	70.81	5.39	2.88	2.16	1.08	2.16	1.80	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	143.28	37.55	17.48	0.93	4.03	0.62	0.62	0.52	0.31	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	310.30	87.09	68.85	2.74	8.21	0.46	2.05	0.46	1.14	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	419.14	140.55	95.24	4.20	5.45	1.26	0.42	1.68	2.52	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	204.43	69.34	48.87	4.33	3.29	1.20	0.75	0.60	0.45	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	152.83	62.85	39.65	3.41	3.41	0.79	0.79	0.96	0.26	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	291.58	46.39	23.19	4.05	4.79	0.74	0.74	1.84	1.10	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	466.72	153.95	128.48	6.87	7.73	1.72	1.72	3.15	3.43	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	905.18	403.75	242.50	7.58	6.32	1.26	2.95	8.00	7.16	5.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	408.72	155.72	77.18	5.94	5.02	0.00	1.37	3.20	1.83	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	436.88	182.37	96.43	6.39	8.44	2.56	2.30	2.30	2.30	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	413.58	180.61	90.57	6.02	7.85	1.57	2.62	4.45	2.88	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	394.35	174.38	85.03	4.93	7.09	1.54	2.16	4.31	1.85	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	428.82	186.17	101.91	6.12	6.59	0.94	1.18	3.06	2.12	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	419.01	192.58	100.86	4.40	9.82	1.02	0.34	1.35	2.03	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	432.66	219.67	118.68	8.25	6.68	0.39	1.96	3.54	3.14	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	385.07	209.45	118.16	4.63	9.27	1.85	1.85	5.56	2.32	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	483.04	627.95	193.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	482.52	244.29	126.04	10.67	11.54	0.87	2.60	2.31	2.60	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	460.03	205.03	111.77	6.02	9.82	1.12	2.45	4.02	1.56	2.90
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	436.24	218.72	124.50	8.65	10.09	0.96	1.44	4.09	3.61	2.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	485.46	184.80	142.27	5.13	6.60	0.73	2.20	1.47	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	372.91	187.30	95.66	5.71	7.05	0.67	2.01	1.68	3.02	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	405.69	198.96	102.75	5.73	10.64	1.23	0.41	5.32	0.41	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	416.67	212.20	106.10	7.73	6.01	0.43	3.01	3.87	2.15	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	615.24	142.19	103.91	8.20	2.73	5.47	5.47	2.73	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	418.36	191.10	108.46	0.00	5.16	10.33	5.16	25.82	15.49	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	421.25	182.53	98.09	7.79	9.74	1.62	1.95	4.87	4.55	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	414.67	183.33	117.85	7.27	11.64	0.00	1.45	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	500.03	194.04	103.42	3.73	9.60	1.07	1.07	6.40	3.73	5.86
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	439.96	184.82	99.77	5.72	9.81	0.82	2.45	3.27	3.27	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	454.80	180.37	87.85	6.61	12.05	1.55	1.17	8.94	2.72	6.61
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	434.44	182.59	86.05	2.10	18.89	0.00	0.00	18.89	10.49	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	469.91	163.92	100.34	3.97	11.92	0.00	1.99	5.96	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	333.71	143.02	85.81	0.00	9.53	0.00	0.00	28.60	4.77	14.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	490.98	148.83	83.61	4.15	6.52	1.78	1.78	7.12	4.15	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	497.13	224.20	141.34	6.09	13.40	3.66	8.53	12.18	3.66	4.87
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	568.10	324.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	524.44	210.92	127.31	5.70	10.13	3.17	3.17	5.70	5.07	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	373.53	229.02	107.27	5.52	8.28	0.34	1.72	10.69	3.79	4.83
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	335.28	268.65	116.06	4.30	12.90	4.30	2.15	23.64	4.30	15.04
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	367.25	159.67	119.75	0.00	7.98	0.00	0.00	7.98	3.99	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	247.96	206.63	75.77	6.89	3.44	0.00	0.00	10.33	3.44	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	279.12	160.95	76.60	2.04	3.67	0.41	0.81	4.07	2.04	2.85
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	285.20	206.55	78.65	2.38	3.18	1.59	0.00	5.56	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	382.60	215.77	118.49	5.90	8.25	0.59	0.59	10.61	8.25	5.90
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	484.08	237.52	103.80	2.81	5.92	1.87	0.94	7.17	2.18	2.81
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	421.05	249.96	108.27	1.34	4.01	1.34	2.67	16.04	2.67	10.69
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	548.76	251.91	121.82	5.91	11.83	1.18	1.18	14.19	9.46	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	544.42	297.89	141.24	2.57	12.84	0.00	0.00	41.09	7.70	23.11
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	541.77	290.50	121.85	3.44	7.57	1.38	0.69	15.83	5.51	4.82
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	1178.63	193.47	89.07	4.45	13.36	0.49	0.99	9.90	7.42	7.42
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	881.50	178.32	76.26	7.85	10.09	0.00	0.00	20.19	6.73	6.73
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1029.15	174.92	92.87	4.45	14.63	1.27	0.00	20.99	3.18	12.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	977.23	29.82	16.52	2.42	9.27	1.21	0.81	5.64	3.22	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	900.58	37.07	13.08	2.18	6.54	0.00	0.00	6.54	4.36	8.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	751.37	30.41	15.20	3.80	7.60	2.53	0.00	5.07	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	244.58	7.89	4.25	2.43	4.25	0.61	0.00	1.82	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	234.99	22.59	0.00	0.00	0.00	0.00	0.00	4.52	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	240.51	12.36	3.29	0.00	4.12	2.47	0.00	3.29	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	542.10	83.74	32.54	3.97	4.96	0.60	0.79	3.37	0.60	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	588.31	69.12	27.26	2.92	4.87	0.00	1.62	4.22	0.65	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	405.41	70.29	27.50	3.06	8.15	0.00	1.02	11.20	4.07	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	524.58	93.62	61.90	2.32	0.77	0.77	1.55	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	1085.77	63.79	50.32	16.77	2.83	4.49	2.13	3.54	0.24	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	87.80	15.99	11.35	4.17	1.16	0.46	0.46	0.00	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	111.11	81.20	38.46	0.00	0.00	0.00	0.00	8.55	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	86.41	72.23	79.32	0.62	1.23	0.21	0.82	0.72	0.41	0.41
mesothelioma cell line:Mero-25	10850-111F4	17.93	38.81	36.09	1.36	0.00	0.91	0.00	1.13	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	1238.51	547.38	454.97	14.18	6.11	1.71	2.20	10.02	5.62	11.73
mesothelioma cell line:Mero-48a	10852-111F6	765.04	205.04	112.93	9.52	3.10	1.99	2.88	4.87	3.99	10.41
mesothelioma cell line:Mero-82	10853-111F7	419.44	129.56	108.01	5.26	0.79	0.79	1.31	8.41	1.84	10.51
mesothelioma cell line:Mero-83	10854-111F8	213.63	183.50	150.65	5.28	3.23	0.17	0.85	3.40	1.02	2.04
mesothelioma cell line:Mero-84	10855-111F9	225.22	30.84	25.02	2.02	1.77	0.25	1.26	0.51	0.51	1.26
mesothelioma cell line:Mero-95	10856-111G1	77.85	30.64	9.32	1.66	2.07	0.41	1.04	0.21	0.62	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	240.02	122.25	112.47	2.65	2.15	0.33	1.16	2.82	1.33	1.82
mesothelioma cell line:NCI-H226	10846-111E9	131.58	61.54	56.47	0.54	0.18	0.36	0.18	0.72	1.27	1.99
mesothelioma cell line:NCI-H2452	10848-111F2	334.81	127.26	76.02	4.95	3.07	1.02	1.02	2.22	0.68	2.39
mesothelioma cell line:NCI-H28	10845-111E8	116.55	64.13	34.35	2.80	1.53	1.53	0.51	2.80	1.27	1.02
mesothelioma cell line:No36	10857-111G2	33.27	35.56	15.33	1.30	1.30	0.65	0.33	0.33	0.65	0.33
mesothelioma cell line:ONE58	10858-111G3	148.21	53.65	29.80	2.17	1.63	1.08	0.00	2.17	1.63	1.63
migratory langerhans cells, donor1	11901-125F2	1.54	0.58	0.19	0.96	0.00	1.73	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	0.73	0.00	0.12	0.00	0.00	1.22	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	2.33	0.18	0.36	1.26	0.00	0.72	0.18	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	94.03	87.17	49.95	3.92	0.33	0.65	0.00	4.57	3.92	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	82.02	40.27	16.11	6.57	2.12	1.48	1.27	1.70	0.42	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	242.34	61.28	53.67	10.14	1.15	1.61	2.30	3.69	0.69	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	102.38	0.95	0.19	6.66	0.19	7.99	0.19	0.38	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	79.26	0.40	0.20	2.77	0.20	1.58	0.00	0.00	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	1087.63	14.71	14.20	4.06	1.01	1.01	3.04	5.07	1.52	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	290.48	144.75	48.84	2.55	1.37	1.18	0.39	1.96	1.37	1.77
nasal epithelial cells, donor1, tech_rep1	12226-129F3	45.35	44.46	15.38	4.12	0.67	2.12	0.22	0.22	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	37.29	40.08	19.12	3.97	0.29	2.21	0.37	0.15	0.15	0.00
nasal epithelial cells, donor2	12227-129F4	95.49	177.74	93.29	5.52	0.55	1.10	1.10	0.00	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	1185.41	623.18	369.06	10.12	1.27	1.05	2.32	6.75	5.27	5.48
neuroblastoma cell line:NH-12	10555-107I6	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	510.75	538.98	198.80	2.37	2.61	0.00	2.85	15.42	4.51	13.76
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1035.49	804.26	397.69	5.54	4.75	0.32	4.12	12.67	7.60	11.88
neuroectodermal tumor cell line:TASK1	10774-110F9	97.21	97.21	30.19	1.01	1.61	0.40	0.20	2.42	0.60	2.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	448.85	178.65	96.64	0.00	0.64	0.00	1.27	10.17	3.18	4.45
neurofibroma cell line:Hs 53.T	10729-110A9	1011.97	144.79	77.45	6.12	9.58	1.06	3.73	5.06	0.80	2.40
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	175.37	62.52	25.33	3.53	3.21	1.28	0.96	4.81	1.28	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	738.37	234.65	160.81	9.20	3.15	1.58	3.68	3.15	7.36	1.58
nucleus accumbens, adult, pool1	10037-101F1	10.97	5.25	7.22	0.19	0.09	0.00	0.00	0.00	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	12.36	2.06	2.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	26.84	6.17	7.78	0.54	0.00	0.27	0.00	0.27	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	20.38	9.10	12.74	1.09	1.46	0.00	0.36	0.73	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	3.67	4.99	3.41	0.52	0.00	0.00	0.00	0.26	0.26	0.52
occipital lobe, fetal, donor1	10073-102A1	9.87	6.44	4.72	0.00	0.86	0.00	0.00	0.86	0.00	0.00
occipital pole, adult, pool1	10036-101E9	8.12	2.68	3.07	0.00	0.32	0.08	0.00	0.00	0.00	0.00
olfactory region, adult	10195-103E6	21.40	5.73	4.39	0.19	0.76	0.19	0.19	0.00	0.19	0.00
optic nerve, donor1	10277-104E7	28.01	8.00	4.00	2.00	0.00	0.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	434.79	394.58	431.37	5.47	1.71	1.03	0.34	1.03	2.28	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	443.90	231.08	201.96	4.40	0.41	0.55	0.55	1.10	1.10	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	120.73	273.63	282.26	1.52	1.19	0.17	0.85	4.06	1.86	2.88
oral squamous cell carcinoma cell line:SAS	10544-107H4	793.66	453.26	276.41	8.55	3.47	2.77	4.50	4.39	3.35	1.39
osteoclastoma cell line:Hs 706.T	10704-109H2	214.30	109.36	75.26	2.35	2.94	0.29	0.59	2.94	0.59	3.53
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	73.81	15.88	31.77	2.80	0.00	0.93	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	82.29	50.31	43.15	1.66	1.40	0.96	0.26	0.09	0.09	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	341.16	120.26	71.86	7.52	2.75	1.10	1.28	4.40	1.47	2.57
pancreas, adult, donor1	10049-101G4	5.64	5.64	11.29	1.88	0.00	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	28.51	0.56	0.56	0.00	0.00	0.00	0.00	0.00	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	257.74	326.91	352.80	4.94	3.24	1.70	1.87	5.62	4.94	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	434.82	126.17	92.06	23.84	1.16	3.81	1.49	0.83	0.83	0.17
paracentral gyrus, adult, pool1	10035-101E8	5.95	3.02	7.05	0.27	0.09	0.09	0.00	0.00	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	9.54	20.55	2.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	2.82	1.88	2.82	0.00	0.00	0.00	0.00	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	14.25	4.85	5.13	0.00	0.00	0.00	0.00	0.29	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	8.64	4.49	7.23	0.18	0.18	0.09	0.09	0.00	0.09	0.09
parietal lobe, fetal, donor1	10072-101I9	13.58	3.88	7.76	0.00	0.00	0.00	0.00	2.91	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	19.81	3.36	10.47	0.75	1.50	0.00	0.37	0.37	0.37	0.00
parotid gland, adult	10199-103F1	44.40	20.35	24.67	0.62	0.00	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	208.94	107.42	130.52	8.59	6.45	3.22	0.54	7.52	2.15	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	255.10	1734.41	744.12	1.30	2.60	0.37	1.30	5.02	5.76	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	649.36	429.07	500.75	54.05	7.28	8.16	2.91	16.32	7.43	14.57
pineal gland - adult, donor10196	10179-103C8	4.52	2.58	3.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	8.88	3.55	5.92	1.78	0.00	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	3.76	3.14	1.88	0.63	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	15.18	3.04	1.01	0.00	1.01	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	3.13	5.21	3.13	0.00	0.00	0.52	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	3.40	0.00	1.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	201.14	122.23	269.72	2.47	1.08	0.86	0.43	0.43	0.43	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	94.95	2.78	2.25	6.62	0.13	7.55	1.72	0.79	0.26	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	160.00	111.28	65.06	2.02	0.93	0.31	0.47	0.93	0.62	0.00
pons, adult, pool1	10033-101E6	7.14	3.87	6.37	0.09	0.00	0.09	0.00	0.00	0.00	0.17
postcentral gyrus, adult, pool1	10032-101E5	4.62	2.44	5.14	0.09	0.00	0.00	0.00	0.00	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	222.72	122.50	78.07	7.43	3.50	2.91	2.91	1.17	3.06	0.58
prostate cancer cell line:PC-3	10439-106E7	489.51	107.99	95.11	7.44	3.81	1.09	0.73	4.54	0.54	4.72
prostate, adult, pool1	10022-101D4	110.55	92.23	89.60	6.98	2.45	2.27	0.18	0.27	0.63	0.00
putamen, adult, donor10196	10176-103C5	3.30	0.94	0.94	0.24	0.24	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	13.73	3.92	0.00	0.00	0.00	0.00	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	2.19	2.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	8.70	2.66	6.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	23.99	10.50	25.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	15.13	0.00	0.00	0.58	0.00	0.00	0.00	0.00	0.00	0.29
rectum, fetal, donor1	10067-101I4	148.84	159.96	140.49	4.17	5.56	0.00	0.00	11.13	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	289.80	108.33	71.66	10.39	1.27	1.48	0.85	1.06	2.33	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	235.27	104.80	28.99	32.31	1.24	26.92	0.83	2.90	0.83	2.90
retina, adult, pool1	10030-101E3	64.81	28.53	26.04	1.89	0.50	0.20	0.30	0.10	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	197.82	67.25	45.86	1.72	0.49	0.12	1.11	2.09	0.74	2.95
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	210.06	9.00	5.06	0.84	0.00	0.00	0.84	0.56	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	318.30	41.68	23.49	2.27	5.30	1.52	0.76	2.27	0.00	1.52
salivary acinar cells, donor1	11771-123I7	274.67	139.20	74.13	3.40	4.21	0.81	0.97	2.91	0.97	2.27
salivary acinar cells, donor2	11772-123I8	330.17	229.39	110.84	7.02	10.60	1.79	1.24	3.30	1.51	2.34
salivary acinar cells, donor3	11773-123I9	438.28	67.53	31.12	7.94	8.61	5.30	1.99	2.65	1.99	0.66
salivary gland, adult, pool1	10093-102C3	30.89	18.30	21.16	1.72	0.00	1.14	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	138.44	107.16	94.26	2.28	2.53	0.93	0.93	0.25	0.93	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	143.30	105.80	76.88	2.00	1.41	0.71	0.59	1.18	1.06	0.59
seminal vesicle, adult	10201-103F3	75.13	44.97	31.22	1.06	1.59	0.00	0.53	1.06	2.12	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	67.05	17.98	11.90	12.63	2.19	1.21	0.73	0.00	0.73	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	215.40	98.39	55.86	6.54	2.01	0.25	1.26	1.76	2.52	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	357.26	130.46	109.39	5.02	3.01	2.01	3.01	4.01	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	4.97	0.40	0.40	0.54	0.13	0.00	0.13	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	1.11	1.33	0.99	0.11	0.11	0.11	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	6.06	2.19	0.77	3.10	0.13	2.19	0.39	0.00	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	67.39	41.85	61.00	0.00	0.71	0.00	0.00	2.13	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	63.33	45.94	116.58	1.32	0.36	0.24	0.12	0.24	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	54.27	42.21	73.37	0.00	0.00	1.01	0.00	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	176.42	40.71	54.28	0.00	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	272.06	131.93	119.93	9.47	6.31	2.52	1.26	3.16	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1.26	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.96	0.00	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.16	0.00	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	59.00	33.44	38.10	1.79	0.48	0.48	0.12	0.12	0.48	0.12
small intestine, fetal, donor1	10064-101I1	52.09	46.44	38.33	0.98	1.23	0.00	0.25	1.47	0.25	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	279.91	227.70	107.00	9.05	4.39	1.29	0.78	3.88	2.33	2.58
somatostatinoma cell line:QGP-1	10781-110G7	0.54	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	30.05	8.26	6.19	0.46	0.23	0.46	0.00	0.00	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	35.88	8.67	8.67	1.18	0.39	0.00	0.00	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	22.14	4.15	4.84	0.00	0.69	0.00	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	70.13	14.03	29.88	1.83	1.22	0.00	0.00	2.44	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	19.29	8.73	16.99	0.92	0.00	0.92	0.00	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	357.41	57.20	35.99	6.72	9.41	1.34	1.64	2.24	1.05	1.19
spleen, adult, pool1	10025-101D7	42.29	35.35	114.43	0.66	0.00	0.33	0.00	0.11	0.55	0.22
spleen, fetal, pool1	10044-101F8	50.61	50.85	117.99	1.27	0.16	0.40	0.32	0.16	0.16	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	1.04	1.14	0.21	1.14	0.10	3.42	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	50.32	87.72	69.68	4.94	0.76	2.85	0.19	0.95	0.00	1.52
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	55.91	13.98	26.21	4.54	1.40	2.10	1.40	1.40	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	111.81	89.13	65.68	9.77	1.17	1.17	1.17	1.17	0.00	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	606.92	715.42	392.83	66.52	27.58	40.30	12.49	5.74	4.16	3.71
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	17.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	491.18	214.50	104.92	15.23	1.27	4.65	4.65	2.12	1.27	2.12
stomach, fetal, donor1	10062-101H8	382.33	123.88	95.05	3.20	6.41	0.00	3.20	4.27	0.00	3.20
submaxillary gland, adult	10202-103F4	33.04	15.95	26.21	0.57	0.00	0.00	0.00	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	52.76	11.22	5.40	0.21	0.00	0.21	0.00	0.62	0.62	0.00
substantia nigra, adult, donor10258	10371-105G2	9.83	3.10	2.07	0.00	0.00	0.00	0.00	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	26.14	8.48	7.07	0.00	2.12	0.71	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	2.29	0.00	0.00	0.46	0.00	0.23	0.00	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	6.27	3.05	5.26	0.00	0.08	0.00	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	11.40	2.14	3.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	33.84	10.55	3.96	0.00	0.44	0.00	0.00	0.00	0.00	0.44
tenocyte, donor1	11763-123H8	377.38	154.30	50.97	4.89	8.73	0.70	1.75	3.49	3.49	2.09
tenocyte, donor2	11765-123I1	265.91	64.86	17.55	3.82	10.30	2.67	0.76	1.53	1.53	0.76
tenocyte, donor3	11768-123I4	1012.29	296.16	140.48	13.71	19.27	3.34	3.34	5.56	5.93	7.78
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	6.46	1.36	1.19	0.17	0.00	0.00	0.00	0.00	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	6.01	1.54	0.15	0.77	0.00	0.62	0.15	0.00	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	43.39	10.54	7.28	1.39	0.31	0.31	0.62	0.46	0.62	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.96	23.36	13.84	1.27	0.63	0.13	0.51	0.63	0.00	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	13.20	3.27	1.53	0.65	0.11	0.55	0.11	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	40.71	3.91	1.63	0.65	0.00	0.33	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	95.24	67.43	79.46	2.90	1.83	0.75	0.21	0.21	0.64	0.21
testis, adult, pool2	10096-102C6	49.62	19.40	13.53	0.90	0.00	0.45	0.00	0.90	0.00	0.45
thalamus - adult, donor10196	10168-103B6	17.66	5.52	6.62	1.10	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	34.54	9.22	4.38	0.16	0.47	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	0.00	1.54	0.00	0.00	0.00	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	3.29	0.49	1.48	0.00	0.00	0.00	0.16	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	13.23	4.60	5.75	0.00	1.15	0.58	0.58	1.73	0.00	0.00
throat, adult	10209-103G2	86.89	50.18	63.17	5.74	2.25	0.50	1.00	0.50	1.25	0.50
throat, fetal, donor1	10061-101H7	86.84	51.80	88.67	9.14	7.01	1.22	2.13	1.83	1.22	2.13
thymic carcinoma cell line:Ty-82	10803-111A2	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	4.27	5.37	9.05	0.50	0.50	0.70	0.20	0.00	0.00	0.00
thymus, fetal, pool1	10043-101F7	16.42	19.64	39.28	0.94	0.31	1.04	0.21	0.10	0.10	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	107.30	103.98	65.82	2.79	0.27	0.40	1.06	2.93	0.66	1.60
thyroid carcinoma cell line:TCO-1	10783-110G9	498.97	323.24	252.84	5.45	2.37	0.56	2.79	6.15	2.65	6.84
thyroid, adult, pool1	10028-101E1	447.06	67.93	64.11	64.76	39.28	14.93	29.67	0.56	1.03	0.28
thyroid, fetal, donor1	10060-101H6	98.61	40.08	62.22	6.33	6.06	1.05	1.32	3.43	0.79	3.16
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	49.27	33.88	3.08	0.00	3.08	0.00	6.16	0.00	0.00
tongue, adult	10203-103F5	68.61	50.93	91.64	1.63	0.70	1.16	0.00	0.47	0.70	0.47
tongue, fetal, donor1	10059-101H5	108.38	93.01	175.37	1.58	0.79	0.00	0.00	1.58	0.79	3.55
tonsil, adult, pool1	10047-101G2	23.04	9.92	21.74	1.10	0.30	0.50	0.20	0.10	0.00	0.00
trachea, adult, pool1	10029-101E2	49.90	32.39	49.73	2.94	1.06	0.74	0.16	0.25	0.25	0.08
trachea, fetal, donor1	10058-101H4	132.33	65.40	101.56	3.85	2.31	0.77	1.15	2.69	1.54	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	1191.43	166.86	115.14	9.21	7.09	1.77	2.83	3.90	6.73	8.15
transitional-cell carcinoma cell line:5637	10418-106C4	161.60	277.30	303.24	3.34	0.61	0.71	0.51	0.91	0.71	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	876.82	767.77	411.15	15.20	6.42	5.01	6.42	7.52	6.27	3.76
tridermal teratoma cell line:HGRT	10694-109G1	605.00	13.32	17.12	1.90	0.00	0.00	0.00	13.32	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	63.23	28.53	15.83	3.81	1.86	0.59	0.34	0.68	0.42	0.25
umbilical cord, fetal, donor1	10057-101H3	156.49	70.94	47.99	4.17	4.17	0.00	0.00	2.09	4.17	4.17
uterus, adult, pool1	10100-102D1	415.65	144.52	188.54	5.97	4.44	2.22	0.17	0.51	1.02	0.34
uterus, fetal, donor1	10055-101H1	409.54	176.62	115.70	5.63	9.73	1.02	0.51	7.68	2.05	5.63
vagina, adult	10204-103F6	65.27	69.14	63.33	6.46	3.23	0.65	0.00	0.00	0.65	0.65
vein, adult	10191-103E2	145.55	70.14	61.81	2.19	3.07	1.32	0.44	0.44	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	2.14	0.27	0.00	1.07	0.00	0.80	0.00	0.00	0.00	0.00